Nothing Special   »   [go: up one dir, main page]

Next Issue
Volume 21, September-1
Previous Issue
Volume 21, August-1
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
ijms-logo

Journal Browser

Journal Browser

Int. J. Mol. Sci., Volume 21, Issue 16 (August-2 2020) – 353 articles

Cover Story (view full-size image): The intra- and intertumor heterogeneity of cell types and gene mutations as well as the complexity of the microenvironment contribute to limiting the efficacy of the current therapeutic options for high grade glioma. This is further complicated by the presence of several noncoding microRNA whose role is still under evaluation. In this scenario, the identification of molecular biomarkers of response and the use of a multimodal in vivo imaging approach represent unique tools for better understanding tumor features, with the final goal of identifying a cluster of patients that are potential responders to personalized medicine. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Section
Select all
Export citation of selected articles as:
12 pages, 869 KiB  
Article
The Identification of Metabolites and Effects of Albendazole in Alfalfa (Medicago sativa)
by Lucie Raisová Stuchlíková, Martina Navrátilová, Lenka Langhansová, Kateřina Moťková, Radka Podlipná, Barbora Szotáková and Lenka Skálová
Int. J. Mol. Sci. 2020, 21(16), 5943; https://doi.org/10.3390/ijms21165943 - 18 Aug 2020
Cited by 5 | Viewed by 3394
Abstract
Albendazole (ABZ), a widely used anthelmintic drug, enters the environment mainly via livestock excrements. To evaluate the environmental impact of ABZ, the knowledge of its uptake, effects and metabolism in all non-target organisms, including plants, is essential. The present study was designed to [...] Read more.
Albendazole (ABZ), a widely used anthelmintic drug, enters the environment mainly via livestock excrements. To evaluate the environmental impact of ABZ, the knowledge of its uptake, effects and metabolism in all non-target organisms, including plants, is essential. The present study was designed to identify the metabolic pathway of ABZ and to test potential ABZ phytotoxicity in fodder plant alfalfa, with seeds and in vitro regenerants used for these purposes. Alfalfa was chosen, as it may meet manure from ABZ-treated animals in pastures and fields. Alfalfa is often used as a feed of livestock, which might already be infected with helminths. The obtained results showed that ABZ did not inhibit alfalfa seed germination and germ growth, but evoked stress and a toxic effect in alfalfa regenerants. Alfalfa regenerants were able to uptake ABZ and transform it into 21 metabolites. UHPLC-MS/MS analysis revealed three new ABZ metabolites that have not been described yet. The discovery of the parent compound ABZ together with the anthelmintically active and instable metabolites in alfalfa leaves shows that the contact of fodder plants with ABZ-containing manure might represent not only a danger for herbivorous invertebrates, but also may cause the development of ABZ resistance in helminths. Full article
(This article belongs to the Special Issue Identification of Metabolites of Xenobiotics)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Germ length of alfalfa seeds exposed to albendazole (ABZ) in various concentrations (0–10 µM). The data represent the mean ± SD. The controls (0 µM) were exposed to solvent DMSO only.</p>
Full article ">Figure 2
<p>Accumulation of proline in plants exposed to ABZ in various concentrations (0–10 µM). The data represent the mean ± SD (<span class="html-italic">n</span> = 6) expressed as percentage of the control plants (exposed to 0 µM, solvent DMSO only). Significant changes (<span class="html-italic">p</span> &lt; 0.05) are marked with an asterisk.</p>
Full article ">Figure 3
<p>Scheme of the proposed metabolic pathway of ABZ in alfalfa.</p>
Full article ">
15 pages, 2434 KiB  
Article
PPARδ and FOXO1 Mediate Palmitate-Induced Inhibition of Muscle Pyruvate Dehydrogenase Complex and CHO Oxidation, Events Reversed by Electrical Pulse Stimulation
by Hung-Che Chien, Paul L. Greenhaff and Dumitru Constantin-Teodosiu
Int. J. Mol. Sci. 2020, 21(16), 5942; https://doi.org/10.3390/ijms21165942 - 18 Aug 2020
Cited by 7 | Viewed by 4229
Abstract
The mechanisms behind the reduction in muscle pyruvate dehydrogenase complex (PDC)-controlled carbohydrate (CHO) oxidation during chronic high-fat dietary intake are poorly understood, as is the basis of CHO oxidation restoration during muscle contraction. C2C12 myotubes were treated with (300 μM) palmitate or without [...] Read more.
The mechanisms behind the reduction in muscle pyruvate dehydrogenase complex (PDC)-controlled carbohydrate (CHO) oxidation during chronic high-fat dietary intake are poorly understood, as is the basis of CHO oxidation restoration during muscle contraction. C2C12 myotubes were treated with (300 μM) palmitate or without (control) for 16 h in the presence and absence of electrical pulse stimulation (EPS, 11.5 V, 1 Hz, 2 ms). Compared to control, palmitate reduced cell glucose uptake (p < 0.05), PDC activity (p < 0.01), acetylcarnitine accumulation (p < 0.05) and glucose-derived mitochondrial ATP production (p < 0.01) and increased pyruvate dehydrogenase kinase isoform 4 (PDK4) (p < 0.01), peroxisome proliferator-activated receptor alpha (PPARα) (p < 0.01) and peroxisome proliferator-activated receptor delta (PPARδ) (p < 0.01) proteins, and reduced the whole-cell p-FOXO1/t-FOXO1 (Forkhead Box O1) ratio (p < 0.01). EPS rescued palmitate-induced inhibition of CHO oxidation, reflected by increased glucose uptake (p < 0.01), PDC activity (p < 0.01) and glucose-derived mitochondrial ATP production (p < 0.01) compared to palmitate alone. EPS was also associated with less PDK4 (p < 0.01) and PPARδ (p < 0.01) proteins, and lower nuclear p-FOXO1/t-FOXO1 ratio normalised to the cytoplasmic ratio, but with no changes in PPARα protein. Collectively, these data suggest PPARδ, and FOXO1 transcription factors increased PDK4 protein in the presence of palmitate, which limited PDC activity and flux, and blunted CHO oxidation and glucose uptake. Conversely, EPS rescued these metabolic events by modulating the same transcription factors. Full article
(This article belongs to the Special Issue Central and Peripheral Molecular Mechanisms of Metabolism Regulation)
Show Figures

Figure 1

Figure 1
<p>C2C12 myotubes viability with increasing concentration of palmitate. C2C12 myotubes were treated with increasing palmitate concentrations from 0 (control) to 750 μM; (<span class="html-italic">n</span> = 6). ** Significantly different from control (<span class="html-italic">p &lt;</span> 0.01). Data represent mean ± SEM of 6 individual experiments in each study group.</p>
Full article ">Figure 2
<p>C2C12 myotube glucose uptake (<b>A</b>) and cell media lactate concentration (<b>B</b>) after exposure to either standard growth media (CON), 16 h of electrical pulse stimulation (EPS; 11.5 V, 1 Hz, 2 ms), 300 μM palmitate (PAL) or the combination of both palmitate and EPS (PAL + EPS). Significantly different from control (CON, * <span class="html-italic">p &lt;</span> 0.05, ** <span class="html-italic">p &lt;</span> 0.01). Significantly different from palmitate (PAL; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>##</sup> <span class="html-italic">p &lt;</span> 0.01). Significantly different from EPS (<sup>+</sup> <span class="html-italic">p &lt;</span> 0.05, <sup>++</sup> <span class="html-italic">p &lt;</span> 0.01).</p>
Full article ">Figure 3
<p>C2C12 myotube pyruvate dehydrogenase complex (PDC) activity (<b>A</b>) and acetylcarnitine content (<b>B</b>) after exposure to either standard growth media (CON), 16 h of electrical pulse stimulation (EPS; 11.5 V, 1 Hz, 2 ms), 300 μM palmitate (PAL) or the combination of both interventions (PAL + EPS). Significantly different from control (CON; * <span class="html-italic">p &lt;</span> 0.05, ** <span class="html-italic">p &lt;</span> 0.01). Significantly different from palmitate (PAL; <sup>##</sup> <span class="html-italic">p &lt;</span> 0.01). Significantly different from EPS (<sup>++</sup> <span class="html-italic">p &lt;</span> 0.01). Data represent mean ± SEM of 6 individual experiments in each study group.</p>
Full article ">Figure 4
<p>Western blots depicting pyruvate dehydrogenase kinase isoform 4 (PDK4) and α-actin protein bands with their corresponding molecular weights (<b>A</b>), their mean band intensities normalised to α-actin (<b>B</b>) in C2C12 myotube after exposure to either standard growth media (CON), 16 h of electrical pulse stimulation (EPS; 11.5 V, 1 Hz, 2 ms), 300 μM palmitate (PAL) or the combination of both interventions (PAL + EPS). Significantly different from control (CON; ** <span class="html-italic">p &lt;</span> 0.01). Significantly different palmitate (PAL; <sup>##</sup> <span class="html-italic">p &lt;</span> 0.01). Significantly different from EPS (<sup>++</sup> <span class="html-italic">p &lt;</span> 0.01). Data represent mean ± SEM of 6 individual experiments in each study group.</p>
Full article ">Figure 5
<p>C2C12 myotube maximal mitochondrial ATP production rates (MAPR) from pyruvate + malate after exposure to either standard growth media (CON), 16 h of electrical pulse stimulation (EPS; 11.5 V, 1 Hz, 2 ms), 300 μM palmitate (PAL) or the combination of both interventions (PAL + EPS). Significantly different from control (CON, ** <span class="html-italic">p &lt;</span> 0.01). Significantly different from palmitate (PAL, <sup>##</sup> <span class="html-italic">p &lt;</span> 0.01). Significantly different from EPS (<sup>++</sup> <span class="html-italic">p &lt;</span> 0.05). Data represent mean ± SEM of 6 individual experiments in each study group.</p>
Full article ">Figure 6
<p>Western blots depicting PPARα, PPAδ, phosphorylated (<span class="html-italic">p</span>)-FOXO1, total (t)-FOXO1 and α-actin protein bands with their corresponding molecular weights (<b>A</b>), mean band intensities normalised to α-actin for peroxisome proliferator-activated receptor alpha (PPARα) (<b>B</b>), peroxisome proliferator-activated receptor delta (PPARδ) (<b>C</b>), and <span class="html-italic">p</span>/t-FOXO1 (<b>D</b>) protein expression in C2C12 myotubes whole cell lysates after myotube exposure to either standard growth media (CON), 16 h of electrical pulse stimulation (EPS; 11.5 V, 1 Hz, 2 ms), 300 μM palmitate (PAL) or the combination of both interventions (PAL + EPS). Significantly different from control (CON; ** <span class="html-italic">p &lt;</span> 0.01). Significantly different from palmitate (PAL; <sup>##</sup> <span class="html-italic">p &lt;</span> 0.01). Significantly different from EPS (<sup>++</sup> <span class="html-italic">p &lt;</span> 0.01). Data represent mean ± SEM of 6 individual experiments in each study group.</p>
Full article ">Figure 7
<p><span class="html-italic">p</span>- and t-FOXO1 protein expression in nuclear (<b>A</b>) and cytosolic (<b>B</b>) cell fractions and their <span class="html-italic">p</span>-FOXO1/t-FOXO1 ratios normalised to that of nuclear to cytoplasmic factor (<b>C</b>) in C2C12 myotubes after exposure to either standard growth media (CON), 16 h of electrical pulse stimulation (EPS; 11.5 V, 1 Hz, 2 ms), 300 μM palmitate (PAL) or the combination of both interventions (PAL + EPS). Significantly different from control (CON; ** <span class="html-italic">p &lt;</span> 0.01). Significantly different from palmitate (PAL; <sup>##</sup> <span class="html-italic">p &lt;</span> 0.01). Significantly different from EPS (<sup>++</sup> <span class="html-italic">p &lt;</span> 0.01). Data represent mean ± SEM of 6 individual experiments in each study group.</p>
Full article ">Figure 8
<p>A schematic illustration of the underlying mechanism by which palmitate inhibits the carbohydrate (CHO)/glucose-derived pyruvate mitochondrial ATP production through activation of PPARδ- and FOXO1-mediated upregulation of PDK4 protein. Blue upright arrow denotes upregulation and red downward arrow denotes downregulation. CD36, fatty acid translocase; FATP1 insulin-sensitive fatty acid transporter; PDK1, 3-phosphoinositide-dependent kinase-1; GLUT4, glucose transporter isoform 4; IGF, insulin-like growth factor; FFA, free fatty acid; Akt1, serine/threonine-protein kinase 1; PTEN, phosphatase and tensin homolog; PI3K, phosphoinositol 3-kinase; GSK3β, glycogen synthase kinase; IRS-1, insulin receptor substrate 1.</p>
Full article ">
22 pages, 4513 KiB  
Review
Histone H1 Post-Translational Modifications: Update and Future Perspectives
by Marta Andrés, Daniel García-Gomis, Inma Ponte, Pedro Suau and Alicia Roque
Int. J. Mol. Sci. 2020, 21(16), 5941; https://doi.org/10.3390/ijms21165941 - 18 Aug 2020
Cited by 55 | Viewed by 10992
Abstract
Histone H1 is the most variable histone and its role at the epigenetic level is less characterized than that of core histones. In vertebrates, H1 is a multigene family, which can encode up to 11 subtypes. The H1 subtype composition is different among [...] Read more.
Histone H1 is the most variable histone and its role at the epigenetic level is less characterized than that of core histones. In vertebrates, H1 is a multigene family, which can encode up to 11 subtypes. The H1 subtype composition is different among cell types during the cell cycle and differentiation. Mass spectrometry-based proteomics has added a new layer of complexity with the identification of a large number of post-translational modifications (PTMs) in H1. In this review, we summarize histone H1 PTMs from lower eukaryotes to humans, with a particular focus on mammalian PTMs. Special emphasis is made on PTMs, whose molecular function has been described. Post-translational modifications in H1 have been associated with the regulation of chromatin structure during the cell cycle as well as transcriptional activation, DNA damage response, and cellular differentiation. Additionally, PTMs in histone H1 that have been linked to diseases such as cancer, autoimmune disorders, and viral infection are examined. Future perspectives and challenges in the profiling of histone H1 PTMs are also discussed. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Modified positions in histone H1 of <span class="html-italic">Tetrahymena thermophila</span>, <span class="html-italic">Saccharomyces cerevisiae</span>, and <span class="html-italic">Drosophila melanogaster</span>. The positions refer to the mature protein, which lacks the initial methionine. Highlighted in yellow, phosphorylation in cyclin-dependent-kinase (CDK) consensus motifs. Question marks are included in post-translational modifications (PTMs) of ambiguous assignment.</p>
Full article ">Figure 2
<p>Modified positions in linker histones of chicken erythrocytes. (<b>A</b>) PTMs identified in H1 subtypes are shown in the sequence alignment. (<b>B</b>) PTMs identified in H5. The residues of the globular domain are shown inside the box. In yellow, phosphorylated residues located at CDK-consensus motifs. The positions refer to the mature protein, which lacks the initial methionine. The complete sequences and the original sequence alignment are shown in <a href="#app1-ijms-21-05941" class="html-app">Figure S1</a>.</p>
Full article ">Figure 3
<p>Modified positions in mammalian H1 subtypes. The PTMs are shown based on the sequence alignment of the human, mouse, and rat sequence for each subtype. The residues of the globular domain are shown in the box. In yellow, phosphorylated residues located at CDK-consensus motifs. In blue, PTM-hotspots in the globular domain. The positions refer to the mature protein, which lacks the initial methionine. The complete sequences and the original alignments are shown in <a href="#app1-ijms-21-05941" class="html-app">Figure S2</a>.</p>
Full article ">Figure 4
<p>Modifications in histone H1 associated with chromatin compaction during the cell cycle. (<b>A</b>) In interphase, some CDK consensus motifs are phosphorylated presumably by CDK2. H1.2S172p and H1.4S186p have been linked to active transcription by RNAP I and II sites [<a href="#B40-ijms-21-05941" class="html-bibr">40</a>]. H1.5S172p and H1.2S172p have been shown to localize at active transcription sites and replication foci [<a href="#B70-ijms-21-05941" class="html-bibr">70</a>]. (<b>B</b>) In mitosis, H1 is hyperphosphorylated by CDK1 at CDK-consensus motifs and by GSK-3, Aurora B, and PKA at H1.5T10, H1.4S26, and H1.4S35. Those PTMs are thought to contribute to heterochromatin disassembly [<a href="#B69-ijms-21-05941" class="html-bibr">69</a>,<a href="#B70-ijms-21-05941" class="html-bibr">70</a>,<a href="#B71-ijms-21-05941" class="html-bibr">71</a>,<a href="#B83-ijms-21-05941" class="html-bibr">83</a>]. (<b>C</b>) H1.4K25 is methylated by histone methyltransferase G9a and demethylated by JMJD2 [<a href="#B88-ijms-21-05941" class="html-bibr">88</a>,<a href="#B89-ijms-21-05941" class="html-bibr">89</a>]. This modification recruits the heterochromatin protein HP1, promoting heterochromatin formation [<a href="#B69-ijms-21-05941" class="html-bibr">69</a>]. H1.K25 can also be acetylated, which would prevent methylation and HP1 binding [<a href="#B91-ijms-21-05941" class="html-bibr">91</a>]. (<b>D</b>) During mitosis, S26 is phosphorylated by the Aurora B kinase [<a href="#B84-ijms-21-05941" class="html-bibr">84</a>]. This modification inhibits HP1 binding, and thus may favor heterochromatin disassembly [<a href="#B69-ijms-21-05941" class="html-bibr">69</a>].</p>
Full article ">Figure 5
<p>Modifications in histone H1 associated with DNA damage response. (<b>A</b>) In normal conditions, H1.2 is capable of binding p53 and maintaining p53 target genes in a quiescent state. Upon DNA damage, H1.2 is phosphorylated in T145 by DNA-PK, while p53 is acetylated by p300. These modifications disrupt p53-H1.2 interaction, allowing p53 to activate the transcription of its target genes [<a href="#B73-ijms-21-05941" class="html-bibr">73</a>]. (<b>B</b>) H1K84 is acetylated by PCAF. This modification recruits the heterochromatin protein 1 (HP1), leading to chromatin compaction. In response to DNA damage, H1K84ac rapidly decreases, removed by HDAC1. K84 deacetylation facilitates chromatin accessibility to DNA repair machinery. PCAF is gradually recruited, thereby restoring H1K84ac levels and chromatin structure after DNA repair [<a href="#B73-ijms-21-05941" class="html-bibr">73</a>,<a href="#B74-ijms-21-05941" class="html-bibr">74</a>]. (<b>C</b>) H1.2 directly interacts with the ATM, inhibiting MRN complex-dependent ATM recruitment. Upon DNA damage, H1.2S187 is parylated by PARP1, inducing its dissociation from chromatin and its degradation. H1.2 removal allows ATM activation after the recruitment of MRN complex, initiating DNA damage response through phosphorylation of different substrates, including γH2AX [<a href="#B74-ijms-21-05941" class="html-bibr">74</a>]. (<b>D</b>) In response to DNA double-strand breaks, RNF8-UBC13 catalyzes K-63 linked ubiquitylation of H1, providing an initial binding platform for RNF168, which in turn ubiquitylates H2A at K13/K15, and possibly other proteins that recruit DSB repair factors [<a href="#B75-ijms-21-05941" class="html-bibr">75</a>].</p>
Full article ">Figure 6
<p>Modifications in histone H1 associated with cell differentiation. (<b>A</b>) H1.4K33 acetylation is catalyzed by GNC5 and can be deacetylated by class I and class II HDACs H1.4K33ac promotes transcriptional activation by two different mechanisms: by reducing H1.4 affinity for chromatin and by recruiting TAF1 [<a href="#B78-ijms-21-05941" class="html-bibr">78</a>]. (<b>B</b>) During spermatogenesis, male germ cells undergo a unique chromatin remodeling process characterized by the sequential substitution of somatic H1 (the most abundant subtype is H1.1), by testis-specific subtypes (H1t and HILS1), transition proteins (TP), and protamines. The detection of multiple phosphorylated positions in H1.1, H1t, and HILS1 in rat testis, during mouse spermiogenesis, and in human sperm, suggests that phosphorylation of H1 subtypes facilitates protein substitution throughout spermatogenesis [<a href="#B34-ijms-21-05941" class="html-bibr">34</a>,<a href="#B57-ijms-21-05941" class="html-bibr">57</a>,<a href="#B58-ijms-21-05941" class="html-bibr">58</a>]. (<b>C</b>) Citrullination of R53 (referred to H1.2) by PADI4, a residue located in the DNA-binding site of the GD of H1, results in its displacement from chromatin and global chromatin decondensation, which is required for the transcriptional activation of pluripotency genes [<a href="#B45-ijms-21-05941" class="html-bibr">45</a>].</p>
Full article ">
16 pages, 1474 KiB  
Review
Casein Kinase 1α as a Regulator of Wnt-Driven Cancer
by Chen Shen, Anmada Nayak, Ricardo A. Melendez, Daniel T. Wynn, Joshua Jackson, Ethan Lee, Yashi Ahmed and David J. Robbins
Int. J. Mol. Sci. 2020, 21(16), 5940; https://doi.org/10.3390/ijms21165940 - 18 Aug 2020
Cited by 18 | Viewed by 5750
Abstract
Wnt signaling regulates numerous cellular processes during embryonic development and adult tissue homeostasis. Underscoring this physiological importance, deregulation of the Wnt signaling pathway is associated with many disease states, including cancer. Here, we review pivotal regulatory events in the Wnt signaling pathway that [...] Read more.
Wnt signaling regulates numerous cellular processes during embryonic development and adult tissue homeostasis. Underscoring this physiological importance, deregulation of the Wnt signaling pathway is associated with many disease states, including cancer. Here, we review pivotal regulatory events in the Wnt signaling pathway that drive cancer growth. We then discuss the roles of the established negative Wnt regulator, casein kinase 1α (CK1α), in Wnt signaling. Although the study of CK1α has been ongoing for several decades, the bulk of such research has focused on how it phosphorylates and regulates its various substrates. We focus here on what is known about the mechanisms controlling CK1α, including its putative regulatory proteins and alternative splicing variants. Finally, we describe the discovery and validation of a family of pharmacological CK1α activators capable of inhibiting Wnt pathway activity. One of the important advantages of CK1α activators, relative to other classes of Wnt inhibitors, is their reduced on-target toxicity, overcoming one of the major impediments to developing a clinically relevant Wnt inhibitor. Therefore, we also discuss mechanisms that regulate CK1α steady-state homeostasis, which may contribute to the deregulation of Wnt pathway activity in cancer and underlie the enhanced therapeutic index of CK1α activators. Full article
(This article belongs to the Special Issue The Wnt Signaling Pathway in Cancer)
Show Figures

Figure 1

Figure 1
<p>The canonical Wnt signaling pathway. In the Wnt off-state (left), β-catenin, the pivotal transcription coactivator of the Wnt pathway, is degraded by the destruction complex in the cytoplasm. Other Wnt effectors, such as frizzled (Fzd) at the membrane and T cell factor (TCF)/lymphoid enhancer-binding factor 1 (LEF1) transcription factors in the nucleus, are also inhibited to maintain low Wnt activity. In the Wnt on-state (right), Wnt ligands trigger the formation of the signalosome to promote Wnt signal transduction. The function of the destruction complex is inhibited, leading to the stabilization of β-catenin. β-catenin then translocates into the nucleus and binds to TCF/LEF1 to form a transcription complex along with other cofactors to initiate Wnt target transcription. LRP5/6: low-density lipoprotein receptor-related protein 5/6; ZNRF3: E3 ubiquitin ligase zinc- and ring-finger protein 3; RNF43: ring-finger protein 43; Dvl: disheveled; AP2: adapter protein 2; APC: adenomatous polyposis coli; CK1α: casein kinase 1α; GSK3: glycogen synthase kinase 3; Gro/TLE: groucho/transducin-like enhancer of split proteins; Pygo: pygopus; BCL9: B cell lymphoma 9 protein; Ebd1: earthbound 1; RSPO: R-spondin family of secreted ligands; LGR: leucine-rich repeat-containing G-protein coupled receptors; HSPG: heparan sulfate proteoglycans; SIAH1: siah E3 ubiquitin ligase 1; PP2A: protein phosphatase 2A.</p>
Full article ">Figure 2
<p>CK1α splice variants. Human CK1α undergoes alternative splicing to produce four splice variants, as shown. These CK1α splice variants are characterized by the insertion of two polypeptide sequences: a long insertion (L) that contains a nuclear localization signal (NLS) into the protein kinase domain, and a short insertion (S) close to the C-terminus. LS: CK1α with both L and S inserts; S: CK1α with only an S insert; NI: CK1α with no insert; SN: CK1α LS with an N-terminal truncation.</p>
Full article ">Figure 3
<p>CK1α regulatory subunits. Proteins that have been reported to regulate CK1α are shown. These proteins bind to CK1α and lead to indicated regulatory outcomes of CK1α. GLIPR1: glioma pathogenesis-related protein 1; FAM83G: family with sequence similarity 83G protein; DDX3: DEAD-box RNA helicase 3; MDMX: murine double minute X.</p>
Full article ">Figure 4
<p>CK1α activators. (<b>A</b>) The structures of two chemically distinct CK1α activators—pyrvinium and SSTC3—and their inactive analogs—VU-WS211 and SSTC111—respectively, are shown. The red boxes highlight key structures needed for maximal efficacy. (<b>B</b>) A model, highlighting how CK1α activators function to increase the catalytic efficiency of CK1α. (<b>C</b>) A model of the mechanism underlying the differential therapeutic index of CK1α activators in normal tissue and Wnt-driven cancer.</p>
Full article ">
19 pages, 3249 KiB  
Article
CA9 Silencing Promotes Mitochondrial Biogenesis, Increases Putrescine Toxicity and Decreases Cell Motility to Suppress ccRCC Progression
by Jiatong Xu, Songbiao Zhu, Lina Xu, Xiaohui Liu, Wenxi Ding, Qingtao Wang, Yuling Chen and Haiteng Deng
Int. J. Mol. Sci. 2020, 21(16), 5939; https://doi.org/10.3390/ijms21165939 - 18 Aug 2020
Cited by 9 | Viewed by 3920
Abstract
Carbonic anhydrase IX (CA9), a pH-regulating transmembrane protein, is highly expressed in solid tumors, and particularly in clear cell renal cell carcinoma (ccRCC). The catalytic mechanisms of CA9 are well defined, but its roles in mediating cell migration/invasion and survival in ccRCC remain [...] Read more.
Carbonic anhydrase IX (CA9), a pH-regulating transmembrane protein, is highly expressed in solid tumors, and particularly in clear cell renal cell carcinoma (ccRCC). The catalytic mechanisms of CA9 are well defined, but its roles in mediating cell migration/invasion and survival in ccRCC remain to be determined. Here, we confirmed that the mRNA expression of CA9 in ccRCC was significantly higher than that in para-carcinoma tissues from analysis of the datasets in The Cancer Genome Atlas. CA9 knockdown upregulated oxidative phosphorylation-associated proteins and increased mitochondrial biogenesis, resulting in the reversal of the Warburg phenotype and the inhibition of cell growth. Our study revealed that CA9 knockdown upregulated mitochondrial arginase 2 (ARG2), leading to the accumulation of putrescine, which suppressed ccRCC proliferation. Surfaceomics analysis revealed that CA9 knockdown downregulated proteins associated with extracellular matrix (ECM)—receptor interaction and cell adhesion, resulting in decreased cell migration. CA9 silencing also downregulated amino acid transporters, leading to reduced cellular amino acids. Collectively, our data show that CA9 knockdown suppresses proliferation via metabolic reprogramming and reduced cell migration, reaffirming that CA9 is a potential therapeutic target for ccRCC treatment. Full article
(This article belongs to the Special Issue Targeting Mitochondria in Aging and Disease)
Show Figures

Figure 1

Figure 1
<p><span class="html-italic">CA9</span> knockdown inhibits cell growth in clear cell renal cell carcinoma (ccRCC) cells. (<b>A</b>) <span class="html-italic">CA9</span> expression profile across all tumor samples and paired normal tissues. The transcriptome datasets were obtained from The Cancer Genome Atlas (TCGA). Tumor abbreviations are listed in <a href="#app1-ijms-21-05939" class="html-app">Table S1</a>. (<b>B</b>) The mean mRNA level of <span class="html-italic">CA9</span> in ccRCC tissues (num(T) = 523) and normal tissues (num(N) = 72) from TCGA data. (<b>C</b>) mRNA expression of <span class="html-italic">CA9</span> decreased in 786-O-CA9-KD cells compared with control cells, measured by quantitative real-time PCR (qPCR). <span class="html-italic">ACTB</span> was used as a control. (<b>D</b>) Western blotting of CA9 revealed that the expression of CA9 was reduced in 786-O-CA9-KD cells. β-actin was used as a control. (<b>E</b>) Knockdown of <span class="html-italic">CA9</span> in 786-O cells inhibited cell growth compared with control cells. (<b>F</b>) Knockdown of <span class="html-italic">CA9</span> in 769-P cells inhibited cell growth. (<b>G</b>) Overexpression of <span class="html-italic">CA9</span> in 786-O cells promoted cell proliferation. Cell proliferation curves measured by the Cell Counting Kit-8 (CCK-8) assays. Significance was calculated by Student’s t-test. **** <span class="html-italic">p</span> &lt; 0.0001, ** <span class="html-italic">p</span> &lt; 0.01, * <span class="html-italic">p</span> &lt; 0.05; <span class="html-italic">n</span> = 3, mean ± SEM.</p>
Full article ">Figure 2
<p>Functional classification of differentially expressed proteins (DEPs) in proteomics analysis of 786-O <span class="html-italic">CA9</span> knockdown cells compared with control cells. (<b>A</b>) Experimental variations of proteomics analysis between 786-O-CA9-KD cells and control cells. (<b>B</b>) A volcano plot of proteins based on <span class="html-italic">p</span>-values and ratios of protein expressions in 786-O-CA9-KD cells compared with control cells. Blue and red dots indicate the downregulated and upregulated proteins with significant difference (<span class="html-italic">p</span>-values &lt; 0.05, ratios ≤ 0.75 or ≥1.33), respectively. (<b>C</b>) The upregulated and downregulated proteins after <span class="html-italic">CA9</span> knockdown in 786-O cells were classified by Kyoto Encyclopedia of Genes and Genomes (KEGG) BlastKOALA. (<b>D</b>) Numbers of upregulated and downregulated proteins participating in genetic information processing. Most mitochondrial biogenesis proteins were upregulated in <span class="html-italic">CA9</span> knockdown cells. (<b>E</b>) Representative canonical pathways enriched in DEPs after <span class="html-italic">CA9</span> knockdown in 786-O cells, analyzed by IPA (Ingenuity Pathway Analysis).</p>
Full article ">Figure 3
<p><span class="html-italic">CA9</span> knockdown increases mitochondrial biogenesis in 786-O cells. (<b>A</b>) Sixteen oxidative phosphorylation (OXPHOS)-related proteins and (<b>B</b>) 28 mitochondrial ribosomal proteins were upregulated in <span class="html-italic">CA9</span> knockdown cells (<span class="html-italic">n</span> = 3, mean ± SEM). (<b>C</b>) <span class="html-italic">CA9</span> knockdown increased MitoTracker staining intensity (**** <span class="html-italic">p</span> &lt; 0.0001, <span class="html-italic">n</span> = 4, mean ± SEM). (<b>D</b>) Western blot images of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), nuclear factor erythroid 2-related factor 2 (NRF2), mitochondrial transcription factor 1 (TFAM), ATP synthase subunit delta (ATP5D) and ATP synthase mitochondrial F1 complex assembly factor 1 (ATPAF1) in control cells and CA9-KD cells. β-actin was used as a control. <span class="html-italic">CA9</span> knockdown enhanced protein expressions of key factors in mitochondrial biogenesis in 786-O cells.</p>
Full article ">Figure 4
<p><span class="html-italic">CA9</span> knockdown increases putrescine production from arginine and inhibits cell growth. (<b>A</b>) A volcano plot of metabolites in 786-O-CA9-KD cells compared with control cells. The plot displays the fold changes of metabolite contents between CA9-KD cells and control cells against the <span class="html-italic">p</span>-values (−log10). Blue and red dots indicate the decreased and increased metabolites with significant difference (<span class="html-italic">p</span>-values &lt; 0.05, fold changes ≤ 0.75 or ≥1.33), respectively. (<b>B</b>) Boxplots of metabolite intensity in putrescine synthesis pathway in CA9-KD cells and control cells (<span class="html-italic">n</span> = 5, mean ± SEM). (<b>C</b>) Schematic representation of putrescine biosynthesis from <sup>13</sup>C<sub>6</sub>-arginine; red dots represent heavy carbon with <sup>13</sup>C labeling while black dots represent light carbon (<sup>12</sup>C). The blue rectangles indicate metabolites and orange ovals indicate related enzymes. ODC, ornithine decarboxylase; ARG2, arginase 2; ASS1, argininosuccinate synthase 1; ASL, argininosuccinate lyase; SMS, spermine synthase; OTC, ornithine carbamoyltransferase. (<b>D</b>) Isotope relative abundance of M+5 ornithine, M+5 citrulline, and M+4 putrescine in 786-O-CA9-KD cells and control cells. Cells were supplemented with <sup>13</sup>C<sub>6</sub>-arginine for 12 h prior to quantify metabolite levels via mass spectroscopy analysis (<span class="html-italic">n</span> = 3, mean ± SEM). (<b>E</b>) Expression ratios of enzymes involved in the putrescine synthesis between 786-O-CA9-KD cells and control cells (<span class="html-italic">n</span> = 3, mean ± SEM). (<b>F</b>) ARG2 and ODC were upregulated after <span class="html-italic">CA9</span> knockdown, while ASS1 and ASL were downregulated, confirmed by Western blotting. β-actin was used as a control. (<b>G</b>) Putrescine inhibited the growth of 786-O cells. The viability was assessed by the CCK-8 assay (<span class="html-italic">n</span> = 3, mean ± SEM). **** <span class="html-italic">p</span> &lt; 0.0001, *** <span class="html-italic">p</span> &lt; 0.001, * <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 5
<p><span class="html-italic">CA9</span> silencing downregulated expressions of amino acid transporters and proteins associated with cell motility in ccRCC cells. (<b>A</b>) Abundance of amino acids in 786-O-CA9-KD cells and control cells. Most amino acids were reduced in <span class="html-italic">CA9</span> knockdown cells (**** <span class="html-italic">p</span> &lt; 0.0001, *** <span class="html-italic">p</span> &lt; 0.001, ns: no significance; <span class="html-italic">n</span> = 5, mean ± SEM). (<b>B</b>) Experimental design for the surfaceomics analysis. (<b>C</b>) Six amino acid transporters were downregulated in <span class="html-italic">CA9</span> knockdown cells (<span class="html-italic">n</span> = 3, mean ± SEM). (<b>D</b>) mammalian target of rapamycin (mTOR) pathway was inactivated in <span class="html-italic">CA9</span> knockdown cells, assessed by Western blotting of phosphor-mTOR (Ser2448), phospho-p70S6K (Thr389), and phospho-4EBP1 (Thr37/46). β-actin was used as a control. (<b>E</b>) Numbers of upregulated and downregulated surface proteins involved in cell motility. (<b>F</b>) The downregulated surface proteins in <span class="html-italic">CA9</span> knockdown cells analyzed by Gene Ontology with DAVID 6.8. (<b>G</b>) Cell migration was inhibited in 786-O-CA9-KD cells compared with that in control cells, assessed by the wound healing assay. Cells were imaged at 0, 12, and 24 h after scratching. Scale bar: 200 μm.</p>
Full article ">
22 pages, 1979 KiB  
Review
Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer
by David N. Brindley, Xiaoyun Tang, Guanmin Meng and Matthew G. K. Benesch
Int. J. Mol. Sci. 2020, 21(16), 5938; https://doi.org/10.3390/ijms21165938 - 18 Aug 2020
Cited by 33 | Viewed by 5090
Abstract
Autotaxin (ATX) is a secreted enzyme that produces lysophosphatidate (LPA), which signals through six G-protein coupled receptors, promoting tumor growth, metastasis, and survival from chemotherapy and radiotherapy. Many cancer cells produce ATX, but breast cancer cells express little ATX. In breast tumors, ATX [...] Read more.
Autotaxin (ATX) is a secreted enzyme that produces lysophosphatidate (LPA), which signals through six G-protein coupled receptors, promoting tumor growth, metastasis, and survival from chemotherapy and radiotherapy. Many cancer cells produce ATX, but breast cancer cells express little ATX. In breast tumors, ATX is produced by tumor-associated stroma. Breast tumors are also surrounded by adipose tissue, which is a major bodily source of ATX. In mice, a high-fat diet increases adipocyte ATX production. ATX production in obesity is also increased because of low-level inflammation in the expanded adipose tissue. This increased ATX secretion and consequent LPA signaling is associated with decreased adiponectin production, which results in adverse metabolic profiles and glucose homeostasis. Increased ATX production by inflamed adipose tissue may explain the obesity-breast cancer association. Breast tumors produce inflammatory mediators that stimulate ATX transcription in tumor-adjacent adipose tissue. This drives a feedforward inflammatory cycle since increased LPA signaling increases production of more inflammatory mediators and cyclooxygenase-2. Inhibiting ATX activity, which has implications in breast cancer adjuvant treatments, attenuates this cycle. Targeting ATX activity and LPA signaling may potentially increase chemotherapy and radiotherapy efficacy, and decrease radiation-induced fibrosis morbidity independently of breast cancer type because most ATX is not derived from breast cancer cells. Full article
Show Figures

Figure 1

Figure 1
<p>Overview of lysophosphatidate (LPA) signaling pathway. Extracellular LPA is produced from the enzymatic action of autotaxin (ATX) on lysophosphatidylcholine (LPC). LPA is degraded by lipid phosphate phosphatases (LPP)1–3 into inactive monoacylglycerol (MAG). LPA signals through at least six known G-protein coupled receptors (with three sub-units) to mediate its downstream cellular effects, which are dependents on the coupling and/or subunit type.</p>
Full article ">Figure 2
<p>Breast cancer cells are poor producers of autotaxin (ATX) compared to adjacent adipose tissue tumor-associated fibroblasts. (<b>A</b>) Human breast cancer cells express little ATX compared to other neuroblastoma, melanoma, glioma, thyroid, and liver cancer cells. Results are means ± SEM. Numbers in parentheses indicates the number of cell lines. Results taken from cBioPortal (<a href="http://www.cbiportal.org" target="_blank">www.cbiportal.org</a>) [<a href="#B63-ijms-21-05938" class="html-bibr">63</a>,<a href="#B64-ijms-21-05938" class="html-bibr">64</a>] and are reproduced from Reference [<a href="#B29-ijms-21-05938" class="html-bibr">29</a>] with permission. (<b>B</b>) ATX mRNA expression in 176 human breast tumors and 10 normal breast tissue specimens. Box plots show minimum, mean, and maximum values, 25th, 50th, and 75th percentiles (box), and 1st and 99th percentiles. Results are expressed relative to the mean of the breast tumor results, which were given the value of 1. * <span class="html-italic">p</span> &lt; 0.001. Adapted from Reference [<a href="#B67-ijms-21-05938" class="html-bibr">67</a>]. (<b>C</b>) ATX, mRNA, and activity levels are significantly lower in tumors compared to adjacent fat pads in orthotopic syngeneic and immunocompetent mouse models (4T1/BALB/C, E0771/C57BL/6) * <span class="html-italic">p</span> &lt; 0.05 by a paired <span class="html-italic">t</span>-test. Results are expressed relative to the mean of the breast tumor results, which were given the value of 1. Includes results adapted from Reference [<a href="#B14-ijms-21-05938" class="html-bibr">14</a>]. (<b>D</b>) Relative ATX mRNA and activity levels in patient-matched Hs578T breast cancer cells and Hs578Bst stromal cells. Results are means ± SEM from three independent experiments. * <span class="html-italic">p</span> &lt; 0.05 vs. Hs578T breast cancer cells. Adapted from Reference [<a href="#B67-ijms-21-05938" class="html-bibr">67</a>]. (<b>E</b>) ATX expression in mouse 4T1 tumors comes predominantly from cancer-associated fibroblasts. Whole 4T1 tumors were enzymatically digested and sorted by flow cytometry for cancer cells (epithelial cells) using EPCAM (epithelial cell adhesion molecule), leukocytes using CD-45, endothelial cells using CD-31, and cancer-associated fibroblasts using platelet-derived growth factor alpha (PDGFα). ATX mRNA levels are expressed relative to those in the whole tumor. Results are means ± SEM from three independent experiments for whole tumor and cancer cells, and means ± range for two independent experiments for leukocytes, endothelial cells, and fibroblasts.</p>
Full article ">Figure 3
<p>ATX is induced in tumor-associated compared to normal breast adipose tissue. (<b>A</b>) ATX immunohistochemical staining is increased in human tumor stroma compared to adjacent breast stroma. * <span class="html-italic">p</span> &lt; 0.001 by paired <span class="html-italic">t</span>-test. Staining intensity was quantified by ImageJ [(NIH), Bethesda, MD, USA] and the results were adapted from Reference [<a href="#B67-ijms-21-05938" class="html-bibr">67</a>]. (<b>B</b>) ATX mRNA and activity levels are higher in tumor-bearing mammary fat pads compared to unaffected contralateral fat pads in a 4T1 orthotopic, synergistic, and immunocompetent BALB/C mouse model. ATX staining and mRNA levels are expressed relative to the breast stroma and contralateral fat pad, respectively. * <span class="html-italic">p</span> &lt; 0.05 by paired <span class="html-italic">t</span>-test. Results adapted from Reference [<a href="#B14-ijms-21-05938" class="html-bibr">14</a>].</p>
Full article ">Figure 4
<p>Overview of ATX/LPA signaling within the breast tumor microenvironment. Breast cancer cells produce virtually no ATX relative to tumor stroma and surrounding adipose tissue. Instead, as cancer cells grow, they establish an inflammatory milieu where inflammatory mediators (IM) (red arrows) stimulate both tumor stroma cells, including tumor-associated fibroblasts, and adjacent adipose tissue to increase ATX production. The tumor also recruits other circulating cells including macrophages to further increase inflammatory signaling and promote a pro-survival and pro-growth environment. Increased ATX enzymatic activity increases tumor LPA concentrations (green arrows), which, thereby, initiates a vicious cycle that further fuels tumor growth and ultimately metastasis.</p>
Full article ">Figure 5
<p>ATX signaling protects cancers cells from cytotoxic effects of radiotherapy and chemotherapy. Lysophosphatidate (LPA) signaling stabilizes Nrf2 expression via PI3K-mediated survival pathways [<a href="#B115-ijms-21-05938" class="html-bibr">115</a>]. Nrf2 facilitates expression of proteins involved in DNA repair and antioxidant pathways as well as increases expression of multidrug-resistant transporters on the cancer cell surface for export of drug and oxidized molecules from the cell [<a href="#B29-ijms-21-05938" class="html-bibr">29</a>]. Combined, these mechanisms contribute to cancer cell survival and resistance to cancer therapy.</p>
Full article ">
22 pages, 1091 KiB  
Review
Anterograde Neuronal Circuit Tracers Derived from Herpes Simplex Virus 1: Development, Application, and Perspectives
by Dong Li, Hong Yang, Feng Xiong, Xiangmin Xu, Wen-Bo Zeng, Fei Zhao and Min-Hua Luo
Int. J. Mol. Sci. 2020, 21(16), 5937; https://doi.org/10.3390/ijms21165937 - 18 Aug 2020
Cited by 9 | Viewed by 5837
Abstract
Herpes simplex virus type 1 (HSV-1) has great potential to be applied as a viral tool for gene delivery or oncolysis. The broad infection tropism of HSV-1 makes it a suitable tool for targeting many different cell types, and its 150 kb double-stranded [...] Read more.
Herpes simplex virus type 1 (HSV-1) has great potential to be applied as a viral tool for gene delivery or oncolysis. The broad infection tropism of HSV-1 makes it a suitable tool for targeting many different cell types, and its 150 kb double-stranded DNA genome provides great capacity for exogenous genes. Moreover, the features of neuron infection and neuron-to-neuron spread also offer special value to neuroscience. HSV-1 strain H129, with its predominant anterograde transneuronal transmission, represents one of the most promising anterograde neuronal circuit tracers to map output neuronal pathways. Decades of development have greatly expanded the H129-derived anterograde tracing toolbox, including polysynaptic and monosynaptic tracers with various fluorescent protein labeling. These tracers have been applied to neuroanatomical studies, and have contributed to revealing multiple important neuronal circuits. However, current H129-derived tracers retain intrinsic drawbacks that limit their broad application, such as yet-to-be improved labeling intensity, potential nonspecific retrograde labeling, and high toxicity. The biological complexity of HSV-1 and its insufficiently characterized virological properties have caused difficulties in its improvement and optimization as a viral tool. In this review, we focus on the current H129-derived viral tracers and highlight strategies in which future technological development can advance its use as a tool. Full article
(This article belongs to the Special Issue Herpes Simplex Virus: From Reactivation to Assembly)
Show Figures

Figure 1

Figure 1
<p>Genomes of current H129-derived tracers, and anterograde tracing schematics. (<b>A</b>–<b>E</b>). Genome schematics of current H129-derived polysynaptic tracers. (<b>A</b>) Wildtype H129 (H129-wt). The genome of HSV-1 strain H129 (H129) is composed of 2 regions, unique long (UL) and unique short (US), which are flanked by terminal repeat (TR) and internal repeat (IR), respectively. (<b>B</b>) H129dTK-TT. The coding gene of tdTomato and codon-modified <span class="html-italic">TK</span> (<span class="html-italic">mTK</span>) is linked by the sequence encoding 2A self-cleaving peptide (2A). A LoxP-Stop-LoxP element is placed between CAG promoter (P<sub>CAG</sub>) and tdTomato-2A-TK cassette. WPRE is used as an enhancer, and poly(A) (pA) is used to stop the transcription. The whole expression cassette is inserted into the middle of the <span class="html-italic">TK</span> gene (<span class="html-italic">UL23</span>) in the H129 genome. The original TK is knocked out by being split into 3′- and 5′- parts. (<b>C</b>) H129-EGFP. The EGFP expression cassette with CMV promoter (P<sub>CMV</sub>) and poly(A) is inserted into the H129 genome between <span class="html-italic">UL26/26.5</span> and <span class="html-italic">UL27</span>. (<b>D</b>) H129-G4. The BAC sequence is inserted into the H129 genome between <span class="html-italic">UL22</span> and <span class="html-italic">UL23</span> to generate BAC-H129. The P<sub>CMV</sub> controlled binary-GFP expression cassette is composed of a membrane-bound EGFP (mEGFP) and an EGFP with a 2A linker. Two copies of the binary-GFP expression cassette are inserted into the H129 genome. One is placed between the BAC sequence and <span class="html-italic">UL23</span>, and the other between <span class="html-italic">US7</span> and <span class="html-italic">US8</span>. (<b>E</b>) H129-H8. The GFP expression cassette is composed of EGFP controlled by human ubiquitin C gene promoter (P<sub>hUbc</sub>) and WPRE-pA, which are all flanked by AAV2-ITR. The AAV replicase expression cassette is composed of the AAV2 <span class="html-italic">Rep</span> gene (<span class="html-italic">AAV-Rep</span>) and poly(A) (pA) controlled by P<sub>CMV</sub>. Both cassettes are inserted into the H129 genome between <span class="html-italic">UL37</span> and <span class="html-italic">UL38</span>. (<b>F</b>,<b>G</b>). Genome schematic of current H129-derived monosynaptic tracers. (<b>F</b>) H129-dTK-tdT. The tdTomato expression cassette driven by P<sub>CMV</sub> is inserted into BAC-H129 to replace the <span class="html-italic">TK</span> gene (<span class="html-italic">UL23</span>), resulting in TK deletion. (<b>G</b>) H129-dTK-T2. Another identical tdTomato expression cassette (P<sub>CMV</sub>-tdT) is inserted into the genome of H129-dTK-tdT, between <span class="html-italic">US7</span> and <span class="html-italic">US8</span>. (<b>H</b>,<b>I</b>). Schematic diagram of polysynaptic and monosynaptic tracing. (<b>H</b>) Polysynaptic tracing. The H129 polysynaptic tracers (indicated by the enveloped virion with green genome) are replication-competent. After being injected into the brain region (indicated by syringe and white circle), they infect the local neurons, replicate, and express fluorescent proteins to label the neurons (indicated as green). The produced progeny virions transmit anterogradely to the next order downstream neurons, repeat the replication/transmission processes, and label further downstream neurons. The ideal polysynaptic tracers should not label upstream neurons (indicated as gray) via terminal pickup or retrograde transmission. (<b>I</b>) Monosynaptic tracing. The H129 monosynaptic tracers (indicated by the enveloped virion with red genome) are replication-incompetent due to certain gene deletion. The helper virus, mostly AAV (indicated by the unenveloped virion with green genome), expresses the deficient gene and the fluorescent protein of a different color (indicated as green). After being injected into the same brain region (indicated by syringes and gray circle), the helper virus expresses the gene to complimentarily support the replication of deficient H129 monosynaptic tracer in trans. The produced progeny virions transmit anterogradely to the next order neurons, where there is no helper virus. Then the monosynaptic tracers stop transmitting to the further downstream regions. During the monosynaptic transmission, the monosynaptic tracers label the neurons by expressing the fluorescent protein (indicated as red). Therefore, the initial coinfected neurons (starter neurons, indicated as yellow) are labeled by both H129 tracer (red) and helper (green), and the second-order neurons are labeled only by H129 tracers (indicated as red). No further downstream neurons or upstream neurons were labeled (indicated as gray).</p>
Full article ">Figure 2
<p>The limitations of current H129-derived tracers. (<b>A</b>–<b>C</b>). Limitations of labeling intensity. (<b>A</b>) Some tracers label the neurons with relatively low intensity. (<b>B</b>) Current monosynaptic tracers do not replicate after monosynaptically transmitting to postsynaptic neurons. Labeling intensity in second-order neurons is very low, making the neurites invisible even after immunostaining. (<b>C</b>) The labeling intensity of the entire neuron is not evenly distributed. The soma is labeled much more brightly than the neurites, resulting in axon and axonal terminals that are difficult to observe or even invisible. (<b>D</b>–<b>G</b>). Limitations of the tracer transmission. (<b>D</b>) H129-derived tracers mainly invade the neuron from the soma and transmit further (solid arrow). However, they can also be potentially picked up by the axonal terminal of the upstream neurons (dashed arrows), and label them with the fluorescent protein. (<b>E</b>) Besides the predominant anterograde transmission (solid arrows), H129-derived tracers were reported to potentially transmit retrogradely and label upstream neurons (dashed arrows). (<b>F</b>) H129 may potentially transmit to adjacent neurons from varicosity (indicated as the enlarged region of the axon) (dashed arrows). (<b>G</b>) H129 may potentially infect astrocytes. In astrocytes, H129-dTK may replicate in the absence of helper virus, and the progeny virions may transmit to adjacent neurons (dashed arrows). (<b>H</b>,<b>I</b>). Limitations of cytotoxicity. (<b>H</b>) The polysynaptic tracers (indicated by the enveloped virion with green genome) are replication-competent. Their anterograde transmission requires tracer replication and progeny production. The viral replication causes severe damage or even neuron death (indicated by the cracks). (<b>I</b>) Monosynaptic tracers (indicated by the enveloped virion with red genome) are replication-deficient in the absence of a helper virus. Due to replication deficiency, only a few viral proteins are synthesized, leading to less damage to the cells. Therefore, they show attenuated toxicity to the postsynaptic neurons after monosynaptic transmission (the red neuron). However, under the assistance of the helper virus (indicated by the unenveloped virion with green genome), H129-derived monosynaptic tracers replicate in the starter neurons (the yellow neuron) and cause severe damage to the starter neurons (indicated by the cracks).</p>
Full article ">
18 pages, 1506 KiB  
Review
Molecular and Cellular Factors Associated with Racial Disparity in Breast Cancer
by Manish Charan, Ajeet K. Verma, Shahid Hussain, Swati Misri, Sanjay Mishra, Sarmila Majumder, Bhuvaneswari Ramaswamy, Dinesh Ahirwar and Ramesh K. Ganju
Int. J. Mol. Sci. 2020, 21(16), 5936; https://doi.org/10.3390/ijms21165936 - 18 Aug 2020
Cited by 17 | Viewed by 5422
Abstract
Recent studies have demonstrated that racial differences can influence breast cancer incidence and survival rate. African American (AA) women are at two to three fold higher risk for breast cancer than other ethnic groups. AA women with aggressive breast cancers show worse prognoses [...] Read more.
Recent studies have demonstrated that racial differences can influence breast cancer incidence and survival rate. African American (AA) women are at two to three fold higher risk for breast cancer than other ethnic groups. AA women with aggressive breast cancers show worse prognoses and higher mortality rates relative to Caucasian (CA) women. Over the last few years, effective treatment strategies have reduced mortality from breast cancer. Unfortunately, the breast cancer mortality rate among AA women remains higher compared to their CA counterparts. The focus of this review is to underscore the racial differences and differential regulation/expression of genetic signatures in CA and AA women with breast cancer. Moreover, immune cell infiltration significantly affects the clinical outcome of breast cancer. Here, we have reviewed recent findings on immune cell recruitment in the tumor microenvironment (TME) and documented its association with breast cancer racial disparity. In addition, we have extensively discussed the role of cytokines, chemokines, and other cell signaling molecules among AA and CA breast cancer patients. Furthermore, we have also reviewed the distinct genetic and epigenetic changes in AA and CA patients. Overall, this review article encompasses various molecular and cellular factors associated with breast cancer disparity that affects mortality and clinical outcome. Full article
(This article belongs to the Special Issue Cytokines/Chemokines in Cancer Metastasis)
Show Figures

Figure 1

Figure 1
<p>Different molecular subtypes of breast cancer.</p>
Full article ">Figure 2
<p>The complex tumor microenvironment of breast cancer.</p>
Full article ">
15 pages, 1782 KiB  
Article
Amorphization of Thiamine Chloride Hydrochloride: Effects of Physical State and Polymer Type on the Chemical Stability of Thiamine in Solid Dispersions
by Seda Arioglu-Tuncil, Adrienne L. Voelker, Lynne S. Taylor and Lisa J. Mauer
Int. J. Mol. Sci. 2020, 21(16), 5935; https://doi.org/10.3390/ijms21165935 - 18 Aug 2020
Cited by 9 | Viewed by 3258
Abstract
Thiamine is an essential micronutrient, but delivery of the vitamin in supplements or foods is challenging because it is unstable under heat, alkaline pH, and processing/storage conditions. Although distributed as a crystalline ingredient, thiamine chloride hydrochloride (TClHCl) likely exists in the amorphous state, [...] Read more.
Thiamine is an essential micronutrient, but delivery of the vitamin in supplements or foods is challenging because it is unstable under heat, alkaline pH, and processing/storage conditions. Although distributed as a crystalline ingredient, thiamine chloride hydrochloride (TClHCl) likely exists in the amorphous state, specifically in supplements. Amorphous solids are generally less chemically stable than their crystalline counterparts, which is an unexplored area related to thiamine delivery. The objective of this study was to document thiamine degradation in the amorphous state. TClHCl:polymer dispersions were prepared by lyophilizing solutions containing TClHCl and amorphous polymers (pectin and PVP (poly[vinylpyrrolidone])). Samples were stored in controlled temperature (30–60 °C) and relative humidity (11%) environments for 8 weeks and monitored periodically by X-ray diffraction (to document physical state) and HPLC (to quantify degradation). Moisture sorption, glass transition temperature (Tg), intermolecular interactions, and pH were also determined. Thiamine was more labile in the amorphous state than the crystalline state and when present in lower proportions in amorphous polymer dispersions, despite increasing Tg values. Thiamine was more stable in pectin dispersions than PVP dispersions, attributed to differences in presence and extent of intermolecular interactions between TClHCl and pectin. The results of this study can be used to control thiamine degradation in food products and supplements to improve thiamine delivery and decrease rate of deficiency. Full article
(This article belongs to the Special Issue Functional Mechanism of B-Vitamins and Their Metabolites 2.0)
Show Figures

Figure 1

Figure 1
<p>X-ray powder diffraction patterns of TClHCl:PVP solid dispersions (SDs) prepared from (<b>A</b>) 50TClHCl:50PVP to 90TClHCl:10PVP, in which all samples exhibited partial crystallinity, and (<b>B</b>) 1TClHCl:99PVP to 40TClHCl:60PVP immediately following lyophilization, in which all samples were amorphous.</p>
Full article ">Figure 2
<p>X-ray powder diffraction patterns of (<b>A</b>) 5TClHCl:95PVP and (<b>B</b>) 5TClHCl:95PEC solid dispersions (SDs) stored at 11% RH and 30–60 °C on day 56.</p>
Full article ">Figure 3
<p>(<b>A</b>) Chemical stability of thiamine in various ratios of TClHCl:PVP solid dispersions (SDs) stored at 11% RH and 60 °C for 56 days. (<b>B</b>) First-order degradation regression lines of thiamine in various ratios of TClHCl:PVP dispersions stored at 11% RH and 60 <b>°</b>C for 56 days.</p>
Full article ">Figure 4
<p>Chemical stability of thiamine in (<b>A</b>) 5TClHCl:95PEC and 5TClHCl:95PVP physical mixtures (PMs) compared to solid dispersions (SDs) stored at 11% RH and 60 <b>°</b>C for 56 days, (<b>B</b>) 5TClHCl:95PEC solid dispersions (SDs) stored at 11% RH and 30–60 <b>°</b>C for 56 days, and (<b>C</b>) 5TClHCl:95PVP solid dispersions (SDs) stored at 11% RH and 30–60 <b>°</b>C for 56 days.</p>
Full article ">Figure 5
<p>Moisture sorption profiles of (<b>A</b>) PVP, PEC, and TClHCl at 25 °C; (<b>B</b>) TClHCl, 40TClHCl:60PVP, 5TClHCl:95PVP, 50TClHCl:50PEC, and 5TClHCl:95PEC solid dispersions (SDs) at 25 °C, with insert graph highlighting initial moisture sorption differences between SDs from 5–50% RH; and (<b>C</b>) 40TClHCl:60PVP, 5TClHCl:95PVP, 50TClHCl:50PEC, and 5TClHCl:95PEC physical mixtures (PMs) at 25 °C. The arrows in the profiles identify 11% RH, the desiccator storage RH, indicating that the moisture contents of all samples were similar at the storage RH.</p>
Full article ">Figure 6
<p>Chemical structures of (<b>A</b>) thiamine, (<b>B</b>) pectin, and (<b>C</b>) PVP.</p>
Full article ">
32 pages, 1886 KiB  
Review
Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD)
by Luis García-Onrubia, Fco. Javier Valentín-Bravo, Rosa M. Coco-Martin, Rogelio González-Sarmiento, J. Carlos Pastor, Ricardo Usategui-Martín and Salvador Pastor-Idoate
Int. J. Mol. Sci. 2020, 21(16), 5934; https://doi.org/10.3390/ijms21165934 - 18 Aug 2020
Cited by 36 | Viewed by 6207
Abstract
Age-related macular degeneration (AMD) is a complex, multifactorial and progressive retinal disease affecting millions of people worldwide. In developed countries, it is the leading cause of vision loss and legal blindness among the elderly. Although the pathogenesis of AMD is still barely understood, [...] Read more.
Age-related macular degeneration (AMD) is a complex, multifactorial and progressive retinal disease affecting millions of people worldwide. In developed countries, it is the leading cause of vision loss and legal blindness among the elderly. Although the pathogenesis of AMD is still barely understood, recent studies have reported that disorders in the regulation of the extracellular matrix (ECM) play an important role in its etiopathogenesis. The dynamic metabolism of the ECM is closely regulated by matrix metalloproteinases (MMPs) and the tissue inhibitors of metalloproteinases (TIMPs). The present review focuses on the crucial processes that occur at the level of the Bruch’s membrane, with special emphasis on MMPs, TIMPs, and the polymorphisms associated with increased susceptibility to AMD development. A systematic literature search was performed, covering the years 1990–2020, using the following keywords: AMD, extracellular matrix, Bruch’s membrane, MMPs, TIMPs, and MMPs polymorphisms in AMD. In both early and advanced AMD, the pathological dynamic changes of ECM structural components are caused by the dysfunction of specific regulators and by the influence of other regulatory systems connected with both genetic and environmental factors. Better insight into the pathological role of MMP/TIMP complexes may lead to the development of new strategies for AMD treatment and prevention. Full article
(This article belongs to the Special Issue Molecular Biology of Age-Related Macular Degeneration (AMD) 2.0)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Age-related macular degeneration (AMD) is an eye disease affecting the macula, a central region in the retina. Individuals affected by AMD in its advanced stage may experience a profound loss of central vision. (<b>A</b>,<b>B</b>) Color pictures of retina with changes typical for early stages of AMD, typified by the presence of numerous large drusen, more or less confluent, and associated (or not) with retinal pigment epithelium (RPE) abnormalities (<span class="html-italic">arrow</span>). (<b>C</b>,<b>D</b>) Color and autofluorescence (AF) pictures of fundus for retina with changes typical for dry AMD. (<b>C</b>) The advanced form of dry AMD is typified by the presence of central geographic atrophy (GA) showing a sharply demarcated atrophic lesion of the outer retina, resulting from the loss of photoreceptors, RPE, and choriocapillaris (<span class="html-italic">asterisk</span>). (<b>D</b>) GA areas typically appear as dark patches in fundus AF images, and can be clearly delineated (<span class="html-italic">asterisk</span>).</p>
Full article ">Figure 2
<p>(<b>A</b>–<b>F</b>) Color, optical coherence tomography (OCT) and fundus fluorescein angiography (FFA) and AF pictures of fundus for retina with changes typical for wet AMD. (<b>A</b>) Wet AMD is characterized by abnormal angiogenesis (choroidal neovascularization (CNV)), causing recurrent retinal exudation, subretinal hemorrhage, retinal or pigment detachment and, in the final stages of the disease, subretinal fibrosis (disciform scar). (<b>B</b>) AF showing confluent atrophic patches (<span class="html-italic">asterisk</span>) with a banded pattern of increased AF in the junction. The CNV can be seen in the OCT-angiography (<span class="html-italic">black star</span>); (<b>C</b>) the structural OCT enables the identification of the abnormal vascular tree (<span class="html-italic">white star</span>) and the presence of subretinal fluid (<span class="html-italic">arrows</span>) (<b>D</b>). By doing an FFA, we can also confirm the presence of the CNV: (<b>E</b>) Early phase: stippled hyperfluorescence with adjacent masking areas by blood or subretinal fibrosis; (<b>F</b>) Late phase: The hyperfluorescence increases irregularly due to the presence of progressive leakage (<span class="html-italic">black arrow-head</span>).</p>
Full article ">Figure 3
<p>Mechanisms for Pro Matrix Metalloproteinase Activation. ProMMP-2 is the only MMP activated on the cell surface by MT-1MMP (MMP-14); this activation requires the trimolecular complex MT1-MMP/TIMP-2/proMMP-2 and the dimerization of the MT1-MMP. Extracellular activation is applicable to many secreted MMPs, such as proMMP-1,3,7,8,9,10,12, and 13, which are activated by a wide type of proteinases. Furin-activated, secreted proMMPs, such as proMMP-11, 14, 23, and 28 are activated intracellularly due to the removal of propeptides by the action of proprotein convertases such as furin. MMP: matrix metalloproteinases; TIMP: tissue metalloproteinase inhibitor; Cl: C-terminal domain of TIMP-2; F: furin recognition site; Zn: zinc of the active site.</p>
Full article ">
26 pages, 2750 KiB  
Review
How Do Molecular Dynamics Data Complement Static Structural Data of GPCRs
by Mariona Torrens-Fontanals, Tomasz Maciej Stepniewski, David Aranda-García, Adrián Morales-Pastor, Brian Medel-Lacruz and Jana Selent
Int. J. Mol. Sci. 2020, 21(16), 5933; https://doi.org/10.3390/ijms21165933 - 18 Aug 2020
Cited by 37 | Viewed by 6533
Abstract
G protein-coupled receptors (GPCRs) are implicated in nearly every physiological process in the human body and therefore represent an important drug targeting class. Advances in X-ray crystallography and cryo-electron microscopy (cryo-EM) have provided multiple static structures of GPCRs in complex with various signaling [...] Read more.
G protein-coupled receptors (GPCRs) are implicated in nearly every physiological process in the human body and therefore represent an important drug targeting class. Advances in X-ray crystallography and cryo-electron microscopy (cryo-EM) have provided multiple static structures of GPCRs in complex with various signaling partners. However, GPCR functionality is largely determined by their flexibility and ability to transition between distinct structural conformations. Due to this dynamic nature, a static snapshot does not fully explain the complexity of GPCR signal transduction. Molecular dynamics (MD) simulations offer the opportunity to simulate the structural motions of biological processes at atomic resolution. Thus, this technique can incorporate the missing information on protein flexibility into experimentally solved structures. Here, we review the contribution of MD simulations to complement static structural data and to improve our understanding of GPCR physiology and pharmacology, as well as the challenges that still need to be overcome to reach the full potential of this technique. Full article
(This article belongs to the Special Issue Computer Simulation on Membrane Receptors and Lipid Bilayers)
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>) Number of G protein-coupled receptors (GPCRs) structures available in GPCRdb [<a href="#B4-ijms-21-05933" class="html-bibr">4</a>,<a href="#B5-ijms-21-05933" class="html-bibr">5</a>] over time. (<b>b</b>) Number of publications per year indexed at Thomson Reuters’ Web of Science that contain the topics “molecular dynamics” and (“GPCR” or “GPCRs”). The exponential growth of successful GPCR research based on molecular dynamics (MD) simulations is evidenced by the rapid upsurge in the number of publications per year related to this subject.</p>
Full article ">Figure 2
<p>Schematic view of the ligand-protein interaction results that can be obtained with the GPCRmd server [<a href="#B53-ijms-21-05933" class="html-bibr">53</a>]. Specifically, the GPCRmd Workbench module of the server enables interactive visualization (GPCRmd Viewer) and analysis (GPCRmd Toolkit) for individual simulations, including ligand-protein interactions among others. Figure obtained from the GPCRmd server [<a href="#B53-ijms-21-05933" class="html-bibr">53</a>].</p>
Full article ">Figure 3
<p>(<b>a</b>) Flowchart summarizing the stages of a MD simulation. (<b>b</b>) Example of a GPCR molecular system, including the β-2 adrenergic receptor (β2AR, blue) with a full agonist in the binding site (orange) in a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) membrane (tails in light brown, heads colored by heteroatom). The system is solvated with water (red) and ionized with sodium (green) and chloride (purple) ions.</p>
Full article ">Figure 4
<p>Example of different parameters analyzed in a 500 ns-long MD simulation of the A<sub>2A</sub> receptor (A<sub>2A</sub>R). (<b>a</b>) Root mean square deviation (RMSD) profile taking as reference the first frame of the simulation, which is superimposed to the rest of the frames. RMSD values (i.e., structural differences with respect to the reference frame) increase over the simulation time until the system reaches a stable conformation after 100 ns. (<b>b</b>) Root mean square fluctuation (RMSF) profile displaying the values of all the alpha carbons in the protein. Higher RMSF values correspond to flexible loops, while lower ones belong to transmembrane helices, where residues are stabilized by the secondary structure. (<b>c</b>) Radius of gyration (RG) profile where the RG fluctuates around the same value during the simulation, indicating that the system does not suffer any big change in compactness. (<b>d</b>) Superimposition of 25 representative frames of the simulated receptor. The relative mobility of loop regions contrasts with the rigidness of the transmembrane helices.</p>
Full article ">Figure 5
<p>Pattern of total interaction frequency of several MD simulations of GPCRs, extracted from the GPCRmd Receptor Meta-analysis tool (<a href="https://submission.gpcrmd.org/contmaps/" target="_blank">https://submission.gpcrmd.org/contmaps/</a>) of the GPCRmd server [<a href="#B53-ijms-21-05933" class="html-bibr">53</a>]. Columns represent interacting residue pairs according to Ballesteros-Weinstein residue numbering [<a href="#B142-ijms-21-05933" class="html-bibr">142</a>], whereas rows represent different simulations. The color of each cell shows the frequency in which any type of non-covalent interaction occurs during the simulation. Results are clustered based on the interaction frequencies of the simulations. This clustering is able to separate simulations according to the receptor subtype, showing that different receptor subtypes present differentiated interaction patterns.</p>
Full article ">
40 pages, 1923 KiB  
Review
Deciphering SARS-CoV-2 Virologic and Immunologic Features
by Grégorie Lebeau, Damien Vagner, Étienne Frumence, Franck Ah-Pine, Xavier Guillot, Estelle Nobécourt, Loïc Raffray and Philippe Gasque
Int. J. Mol. Sci. 2020, 21(16), 5932; https://doi.org/10.3390/ijms21165932 - 18 Aug 2020
Cited by 30 | Viewed by 25882
Abstract
Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 and its associated pathology, COVID-19, have been of particular concerns these last months due to the worldwide burden they represent. The number of cases requiring intensive care being the critical point in this epidemic, a better understanding [...] Read more.
Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 and its associated pathology, COVID-19, have been of particular concerns these last months due to the worldwide burden they represent. The number of cases requiring intensive care being the critical point in this epidemic, a better understanding of the pathophysiology leading to these severe cases is urgently needed. Tissue lesions can be caused by the pathogen or can be driven by an overwhelmed immune response. Focusing on SARS-CoV-2, we and others have observed that this virus can trigger indeed an immune response that can be dysregulated in severe patients and leading to further injury to multiple organs. The purpose of the review is to bring to light the current knowledge about SARS-CoV-2 virologic and immunologic features. Thus, we address virus biology, life cycle, tropism for many organs and how ultimately it will affect several host biological and physiological functions, notably the immune response. Given that therapeutic avenues are now highly warranted, we also discuss the immunotherapies available to manage the infection and the clinical outcomes. Full article
(This article belongs to the Section Molecular Immunology)
Show Figures

Figure 1

Figure 1
<p>SARS-CoV-2 supposed life cycle. (<b>A</b>) Entry of SARS-CoV-2 in target cell expressing ACE2 (or another receptor, CD147 have been evoked but need to be confirmed). (<b>B</b>) Uncoating and releasing SARS-CoV-2 single stranded positive RNA genome. (<b>C</b>) Translation of replicase–transcriptase complex directly from RNA genome. (<b>D</b>) RNA genome replication due to a negative template. (<b>E</b>) Nested production of subgenomic RNA encoding for structural proteins. (<b>F</b>) Translation of viral S, E and M inserted in endoplasmic reticulum. (<b>G</b>) Nucleocapsid coupled to the genome, forming nucleoprotein, combine to S, E and M to form a mature virion (<b>H</b>). (<b>I</b>) Exocytosis of SARS-CoV-2.</p>
Full article ">Figure 2
<p>The two evoked routes of entry for SARS-CoV-2 to date. Angiotensin-converting-enzyme 2 (ACE2), which has been described as an interferon-stimulated gene (ISG), is a route of entry for SARS-CoV-2. Additionally, CD147 is evoked as a potential second route of entry. Based on a previous study with SARS-CoV, an interaction with Cyclophilin A is possible. The blue background corresponds to cells expressing ACE2, whereas the red background is representing cells expressing CD147. Solid arrows correspond to a direct activity involving ACE2, dotted arrows correspond to an indirect promoting activity.</p>
Full article ">Figure 3
<p>Tropism and multiple organ injuries in SARS-CoV-2 infection. SARS-CoV-2 infection has been associated with multiple organ injuries due to viral tropism. Among injured organs (and targeted cell) we can find: lung (type II pneumocyte), heart (cardiomyocyte), liver (cholangiocyte), spleen and lymph nodes (macrophage), kidney and brain.</p>
Full article ">Figure 4
<p>Mild versus severe immune response during SARS-CoV-2 infection. In regards to cytokine signature during SARS-CoV-2, mild and moderate cases showed a controlled response with higher expression of IL-1β, IL-1RA, IL-2RA, IL-6, IL-7, IL-8, IL-9, IL-10, basic FGF, G-CSF, GM-CSF, HGF, IFNγ, IP-10, MCP-1, MIP-1a, MIP-1b, PDGF, TNF-α and VEGF. While, a cytokine-induced immunopathological mechanism has been observed with an increase of IL-2, IL-7, IL-17, IL-10, MCP-1, MIP-1a and TNF-α in severe cases, leading to a bystander effect.</p>
Full article ">Figure 5
<p>Viral sensing, innate antiviral response and immune evasion. Potential mechanisms of SARS-CoV-2 immune evasion based on previous studies on MERS-CoV (brown) and SARS-CoV (blue). Some mechanisms are inhibiting viral sensing, whereas others are directed against the innate antiviral response. Solid arrows correspond to a direct promoting activity, dotted arrows correspond to an indirect promoting activity and T-bars correspond to a direct inhibitory activity.</p>
Full article ">
29 pages, 1197 KiB  
Review
Necroptosis in Hepatosteatotic Ischaemia-Reperfusion Injury
by Raji Baidya, Darrell H. G. Crawford, Jérémie Gautheron, Haolu Wang and Kim R. Bridle
Int. J. Mol. Sci. 2020, 21(16), 5931; https://doi.org/10.3390/ijms21165931 - 18 Aug 2020
Cited by 23 | Viewed by 5010
Abstract
While liver transplantation remains the sole treatment option for patients with end-stage liver disease, there are numerous limitations to liver transplantation including the scarcity of donor livers and a rise in livers that are unsuitable to transplant such as those with excess steatosis. [...] Read more.
While liver transplantation remains the sole treatment option for patients with end-stage liver disease, there are numerous limitations to liver transplantation including the scarcity of donor livers and a rise in livers that are unsuitable to transplant such as those with excess steatosis. Fatty livers are susceptible to ischaemia-reperfusion (IR) injury during transplantation and IR injury results in primary graft non-function, graft failure and mortality. Recent studies have described new cell death pathways which differ from the traditional apoptotic pathway. Necroptosis, a regulated form of cell death, has been associated with hepatic IR injury. Receptor-interacting protein kinase 3 (RIPK3) and mixed-lineage kinase domain-like pseudokinase (MLKL) are thought to be instrumental in the execution of necroptosis. The study of hepatic necroptosis and potential therapeutic approaches to attenuate IR injury will be a key factor in improving our knowledge regarding liver transplantation with fatty donor livers. In this review, we focus on the effect of hepatic steatosis during liver transplantation as well as molecular mechanisms of necroptosis and its involvement during liver IR injury. We also discuss the immune responses triggered during necroptosis and examine the utility of necroptosis inhibitors as potential therapeutic approaches to alleviate IR injury. Full article
(This article belongs to the Special Issue New Frontiers in Organ Preservation and Hepatoprotection)
Show Figures

Figure 1

Figure 1
<p>Overview of the process of ischemia-reperfusion (IR) injury. Upon depletion of oxygen during the ischaemic stage, mitochondria initiate anaerobic metabolism and ATP production decreases. Further, ion-exchange pump channel dysfunction and pH level decreases leading to cell swelling. During the reperfusion stage, mitochondrial swelling and accumulation of H<sup>+</sup>, Na<sup>+</sup> and K<sup>+</sup> result in oxidative stress leading to the excessive production of ROS. This induces cell injury, leading to cell death. The figure is modified from Reference [<a href="#B48-ijms-21-05931" class="html-bibr">48</a>].</p>
Full article ">Figure 2
<p>TNFα-induced cell death pathway. TNFα stimulates TNFR1 to generate complex I by recruiting TRADD, TRAF2 and 5, RIPK1 and cIAP1/2. Polyubiquitination of RIPK1 in complex I will activate the NF-κB pathway, whereas polyubiquitination of RIPK1 by CLYD shifts complex I to cytoplasm to form complex II. Activation of CASPASE8 will result in activation of CASPASE3 and cells undergo apoptosis. Upon inhibition of CASPASE8, activation and phosphorylation of RIPK1 leads to recruitment of RIPK3 and further recruits MLKL to form the necrosome. Further activation of PGAM5 and DRP1 results in ROS production in mitochondria and induces necroptosis. Activation of TLR3/ TLR4 by PAMPs or LPS, activates Toll–IL-1 receptor domain-containing adaptor-inducing IFN-β (TRIF) and RIPK3 binding and triggers necroptosis. Abbreviations: TNF, tumour necrosis factor; TRADD, TNFRSF1A-associated via death domain; TRAF, TNF receptor-associated factors; cIAP, cellular inhibitor of apoptosis protein; CYLD, deubiquitinase cylindromatosis; FADD, FAS-associated death domain; MLKL, mediator mixed-lineage kinase domain like; RIPK, receptor-interacting protein kinase; PGAM5, phosphoglycerate mutase 5; Drp1, dynamin-related protein 1; ROS, reactive oxygen species; TLR3/4, TNF-like death receptors 3/4; PAMPs, pathogen-associated molecular patterns; LPS, lipopolysaccharide. Figure is modified from References [<a href="#B84-ijms-21-05931" class="html-bibr">84</a>,<a href="#B91-ijms-21-05931" class="html-bibr">91</a>,<a href="#B92-ijms-21-05931" class="html-bibr">92</a>].</p>
Full article ">
11 pages, 2615 KiB  
Article
Interactions between the Intrinsically Disordered Regions of hnRNP-A2 and TDP-43 Accelerate TDP-43′s Conformational Transition
by Wan-Chin Chiang, Ming-Hsuan Lee, Tsai-Chen Chen and Jie-rong Huang
Int. J. Mol. Sci. 2020, 21(16), 5930; https://doi.org/10.3390/ijms21165930 - 18 Aug 2020
Cited by 8 | Viewed by 3766
Abstract
Most biological functions involve protein–protein interactions. Our understanding of these interactions is based mainly on those of structured proteins, because encounters between intrinsically disordered proteins (IDPs) or proteins with intrinsically disordered regions (IDRs) are much less studied, regardless of the fact that more [...] Read more.
Most biological functions involve protein–protein interactions. Our understanding of these interactions is based mainly on those of structured proteins, because encounters between intrinsically disordered proteins (IDPs) or proteins with intrinsically disordered regions (IDRs) are much less studied, regardless of the fact that more than half eukaryotic proteins contain IDRs. RNA-binding proteins (RBPs) are a large family whose members almost all have IDRs in addition to RNA binding domains. These IDRs, having low sequence similarity, interact, but structural details on these interactions are still lacking. Here, using the IDRs of two RBPs (hnRNA-A2 and TDP-43) as a model, we demonstrate that the rate at which TDP-43′s IDR undergoes the neurodegenerative disease related α-helix-to-β-sheet transition increases in relation to the amount of hnRNP-A2′s IDR that is present. There are more than 1500 RBPs in human cells and most of them have IDRs. RBPs often join the same complexes to regulate genes. In addition to the structured RNA-recognition motifs, our study demonstrates a general mechanism through which RBPs may regulate each other’s functions through their IDRs. Full article
(This article belongs to the Special Issue Structural Biology of Proteins and Peptides)
Show Figures

Figure 1

Figure 1
<p>Schematic illustration of the intrinsically disordered regions (IDRs) of TDP-43 and hnRNP-A2 in this study. (<b>A</b>,<b>B</b>) The domains of (<b>A</b>) TDP-43 and (<b>B</b>) hnRNP-A2. The level of protein disorder was predicted using the PONDR VSL2 algorithm [<a href="#B36-ijms-21-05930" class="html-bibr">36</a>]. The fragments used in this study are indicated with red-dashed lines. (<b>C</b>) Schematic representation of the α-helical, self-association, and liquid-liquid phase separation propensities of TDP-43 reported in previous publications [<a href="#B37-ijms-21-05930" class="html-bibr">37</a>,<a href="#B38-ijms-21-05930" class="html-bibr">38</a>,<a href="#B39-ijms-21-05930" class="html-bibr">39</a>]. The molecular details of the effects of hnRNP-A2 remain elusive.</p>
Full article ">Figure 2
<p>The interaction between the intrinsically disordered regions (IDRs) of TDP-43 and hnRNP-A2. (<b>A</b>) Overlaid NMR HSQC spectra of 20 µM <sup>15</sup>N TDP-43<sup>266–414</sup> alone (red) and in the presence of 20 µM <sup>14</sup>N-hnRNP-A2<sup>288–341</sup> (green). (<b>B</b>) Overlaid NMR HSQC spectra of 20 µM <sup>15</sup>N- hnRNP-A2<sup>288–341</sup> alone (red) and in the presence of 20 µM <sup>14</sup>N-TDP-43<sup>266–414</sup> (green). (<b>C</b>) Circular dichroism spectra of 20 µM TDP-43<sup>266–414</sup> (blue), hnRNP-A2<sup>288–341</sup> (red), and a one-to-one mixture of the two (purple) overlaid on the summed spectra of the two proteins alone (broken purple line). (<b>D</b>) Fits using BeStSel [<a href="#B41-ijms-21-05930" class="html-bibr">41</a>,<a href="#B42-ijms-21-05930" class="html-bibr">42</a>] of the mixture (left panel) and numerically summed TDP-43/hnRNP-A2 spectra (right) and the proportion of secondary structure components obtained. The residuals of the fits are shown as black bars.</p>
Full article ">Figure 3
<p>The time evolution of NMR HSQC and circular dichroism spectra indicates that conformational change in TDP-43<sup>266–414</sup> is accelerated by the presence of hnRNP-A2<sup>288–341</sup>. (<b>A</b>–<b>C</b>) Time sequences of NMR HSQC spectra of <sup>15</sup>N-TDP-43 (<b>A</b>) in the presence and (<b>C</b>) in the absence of hnRNP-A2<sup>288–341</sup>, and (<b>B</b>) of <sup>15</sup>N hnRNP-A2<sup>288–341</sup> in the presence of TDP-43<sup>266–414</sup>. Assignments are shown for the cross-peaks whose position or intensity clearly change over time. (<b>D</b>–<b>F</b>) Time sequences of NMR peak intensity profiles as a function of residue number for (<b>D</b>) TDP-43<sup>266–414</sup> mixed with hnRNP-A2<sup>288–341</sup> and (<b>E</b>,<b>F</b>) for TDP-43<sup>266–414</sup> alone. (<b>G</b>) Primary sequence of TDP-43<sup>266–414</sup> with residues highlighted in black if the corresponding NMR intensity decreases over time. The α-helical and Q/N rich regions are also indicated. (<b>H</b>–<b>J</b>) Circular dichroism spectra at different incubation times of (<b>H</b>) the mixture sample, (<b>I</b>) TDP-43<sup>266–414</sup> alone and (<b>J</b>) hnRNP-A2<sup>288–341</sup> only.</p>
Full article ">Figure 4
<p>Increasing the amount of hnRNP-A2<sup>288–341</sup> accelerates transitions from α-helix to β-sheet in TDP-43<sup>266–414</sup>. (<b>A</b>–<b>D</b>) Comparisons of the NMR HSQC spectrum of TDP-43<sup>266–414</sup> in the absence of hnRNP-A2<sup>288–341</sup> after 22 h of incubation (red) with the spectra of (<b>A</b>) TDP-43<sup>266–414</sup> alone after ~1 h incubation (black), (<b>B</b>) a 1:1 mixture of TDP-43<sup>266–414</sup> and hnRNP-A2<sup>288–341</sup> after ~9 h of incubation, (<b>C</b>) a 1:3 mixture of TDP-43<sup>266–414</sup> and hnRNP-A2<sup>288–341</sup> after ~3 h of incubation, and (<b>D</b>) a 1:5 mixture of TDP-43<sup>266–414</sup> and hnRNP-A2<sup>288–341</sup> after less than 1 h of incubation. (<b>E</b>–<b>H</b>) Proportions of secondary structure elements derived from CD measurements (upper panel: α-helix; lower panel: antiparallel β-sheet) for the same mixtures at different incubation times.</p>
Full article ">Figure 5
<p>A schematic illustration of the proposed model. In the absence of hnRNP-A2, the IDR of TDP-43 is in equilibrium with both α-helix and coil conformations but tends to aggregate in its coil form (left panel). When the α-helical region of TDP-43′s IDR weakly contacts the IDR of hnRNP-A2 (pink), the coil population of TDP-43 is increased, which enhances its tendency to aggregate (right panel).</p>
Full article ">
14 pages, 621 KiB  
Review
Taste the Pain: The Role of TRP Channels in Pain and Taste Perception
by Edwin N. Aroke, Keesha L. Powell-Roach, Rosario B. Jaime-Lara, Markos Tesfaye, Abhrarup Roy, Pamela Jackson and Paule V. Joseph
Int. J. Mol. Sci. 2020, 21(16), 5929; https://doi.org/10.3390/ijms21165929 - 18 Aug 2020
Cited by 39 | Viewed by 8490
Abstract
Transient receptor potential (TRP) channels are a superfamily of cation transmembrane proteins that are expressed in many tissues and respond to many sensory stimuli. TRP channels play a role in sensory signaling for taste, thermosensation, mechanosensation, and nociception. Activation of TRP channels (e.g., [...] Read more.
Transient receptor potential (TRP) channels are a superfamily of cation transmembrane proteins that are expressed in many tissues and respond to many sensory stimuli. TRP channels play a role in sensory signaling for taste, thermosensation, mechanosensation, and nociception. Activation of TRP channels (e.g., TRPM5) in taste receptors by food/chemicals (e.g., capsaicin) is essential in the acquisition of nutrients, which fuel metabolism, growth, and development. Pain signals from these nociceptors are essential for harm avoidance. Dysfunctional TRP channels have been associated with neuropathic pain, inflammation, and reduced ability to detect taste stimuli. Humans have long recognized the relationship between taste and pain. However, the mechanisms and relationship among these taste–pain sensorial experiences are not fully understood. This article provides a narrative review of literature examining the role of TRP channels on taste and pain perception. Genomic variability in the TRPV1 gene has been associated with alterations in various pain conditions. Moreover, polymorphisms of the TRPV1 gene have been associated with alterations in salty taste sensitivity and salt preference. Studies of genetic variations in TRP genes or modulation of TRP pathways may increase our understanding of the shared biological mediators of pain and taste, leading to therapeutic interventions to treat many diseases. Full article
(This article belongs to the Section Biochemistry)
Show Figures

Figure 1

Figure 1
<p>Role of transient receptor potentials (TRPs) in taste and pain sensation: (<b>A</b>) TRPs involved in pain and taste perception; (<b>B</b>) afferent inputs from nociceptors enter the central nervous system (CNS) via the dorsal root ganglion (DRG) and trigeminal ganglion (TG) for transmission to the cerebral cortex for interpretation. TRPA = transient receptor potential ankyrin; TRPM = transient receptor potential melastatin; TRPV = transient receptor potential vanilloid; TRPC = transient receptor potential-canonical; DRG = dorsal root ganglion; NTS = nucleus tractus solitarius. The blue and purple lines correspond to cranial nerves VII and IX.</p>
Full article ">
23 pages, 1561 KiB  
Article
Tracking Antimicrobial Resistance Determinants in Diarrheal Pathogens: A Cross-Institutional Pilot Study
by Chris R. Taitt, Tomasz A. Leski, Michael G. Prouty, Gavin W. Ford, Vireak Heang, Brent L. House, Samuel Y. Levin, Jennifer A. Curry, Adel Mansour, Hanan El Mohammady, Momtaz Wasfy, Drake Hamilton Tilley, Michael J. Gregory, Matthew R. Kasper, James Regeimbal, Paul Rios, Guillermo Pimentel, Brook A. Danboise, Christine E. Hulseberg, Elizabeth A. Odundo, Abigael N. Ombogo, Erick K. Cheruiyot, Cliff O. Philip and Gary J. Voraadd Show full author list remove Hide full author list
Int. J. Mol. Sci. 2020, 21(16), 5928; https://doi.org/10.3390/ijms21165928 - 18 Aug 2020
Cited by 7 | Viewed by 4327
Abstract
Infectious diarrhea affects over four billion individuals annually and causes over a million deaths each year. Though not typically prescribed for treatment of uncomplicated diarrheal disease, antimicrobials serve as a critical part of the armamentarium used to treat severe or persistent cases. Due [...] Read more.
Infectious diarrhea affects over four billion individuals annually and causes over a million deaths each year. Though not typically prescribed for treatment of uncomplicated diarrheal disease, antimicrobials serve as a critical part of the armamentarium used to treat severe or persistent cases. Due to widespread over- and misuse of antimicrobials, there has been an alarming increase in global resistance, for which a standardized methodology for geographic surveillance would be highly beneficial. To demonstrate that a standardized methodology could be used to provide molecular surveillance of antimicrobial resistance (AMR) genes, we initiated a pilot study to test 130 diarrheal pathogens (Campylobacter spp., Escherichia coli, Salmonella, and Shigella spp.) from the USA, Peru, Egypt, Cambodia, and Kenya for the presence/absence of over 200 AMR determinants. We detected a total of 55 different determinants conferring resistance to ten different categories of antimicrobials: genes detected in ≥ 25 samples included blaTEM, tet(A), tet(B), mac(A), mac(B), aadA1/A2, strA, strB, sul1, sul2, qacEΔ1, cmr, and dfrA1. The number of determinants per strain ranged from none (several Campylobacter spp. strains) to sixteen, with isolates from Egypt harboring a wider variety and greater number of genes per isolate than other sites. Two samples harbored carbapenemase genes, blaOXA-48 or blaNDM. Genes conferring resistance to azithromycin (ere(A), mph(A)/mph(K), erm(B)), a first-line therapeutic for severe diarrhea, were detected in over 10% of all Enterobacteriaceae tested: these included >25% of the Enterobacteriaceae from Egypt and Kenya. Forty-six percent of the Egyptian Enterobacteriaceae harbored genes encoding CTX-M-1 or CTX-M-9 families of extended-spectrum β-lactamases. Overall, the data provide cross-comparable resistome information to establish regional trends in support of international surveillance activities and potentially guide geospatially informed medical care. Full article
(This article belongs to the Special Issue Drug Resistance Mechanisms in Bacteria)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>(<b>A</b>) Number of antimicrobial resistance determinants (ARDs) detected in tested population, by category; numbers in parentheses indicate total ARDs represented on microarray for that category. BLA = β-lactams (53); AG = aminoglycosides (44); MAC = macrolide (40); TET = tetracyclines (38); GLY = glycopeptides (13); ANS = ansamycins (1); MUP = mupirocin (1); PHE = phenicols (20); LIN = lincosamides (6); MLS = macrolides/lincosamides/streptogramins (13); FQ = fluoroquinolones (4); QUA = quaternary amines (2); STR = streptothricin; PT = platensimycin + platencin (1); SUL = sulfonamides (3); AMP = antimicrobial peptides (1); TMP = diaminopyrimidine. (<b>B</b>) Number of ARDs detected per isolate. (<b>C</b>) Prevalence of unique ARDs detected in &gt;10 isolates.</p>
Full article ">Figure 2
<p>Numbers of unique ARDs observed for <span class="html-italic">Campylobacter</span> spp. (yellow), <span class="html-italic">E. coli</span> (orange), <span class="html-italic">Shigella</span> spp. (green), <span class="html-italic">Salmonella</span> (blue), and all species (black) detected in isolates from each collection site.</p>
Full article ">Figure 3
<p>Box and whisker charts showing number of unique ARDs per isolate for (<b>A</b>) <span class="html-italic">E. coli</span>; (<b>B</b>) <span class="html-italic">Shigella</span> spp.; (<b>C</b>) <span class="html-italic">Salmonella</span>; (<b>D</b>) each population as a whole (including <span class="html-italic">Campylobacter</span> spp.). Black squares in each chart indicate mean values.</p>
Full article ">Figure 4
<p>Pie charts showing carriage rates of ARDs conferring resistance to β-lactams, aminoglycosides, tetracyclines, and trimethoprim among <span class="html-italic">E. coli</span>, <span class="html-italic">Shigella</span> spp., and <span class="html-italic">Salmonella</span>. Black pie slices indicate the percentage of isolates that were negative for all tested ARDs in that category. Note that many strains carried multiple β-lactamase and aminoglycoside ARDs.</p>
Full article ">
29 pages, 578 KiB  
Review
Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options
by Daniela Maria Tanase, Evelina Maria Gosav, Ecaterina Neculae, Claudia Florida Costea, Manuela Ciocoiu, Loredana Liliana Hurjui, Claudia Cristina Tarniceriu and Mariana Floria
Int. J. Mol. Sci. 2020, 21(16), 5927; https://doi.org/10.3390/ijms21165927 - 18 Aug 2020
Cited by 37 | Viewed by 11347
Abstract
Nonalcoholic fatty liver disease (NAFLD) is an emerging worldwide problem and its association with other metabolic pathologies has been one of the main research topics in the last decade. The aim of this review article is to provide an up-to-date correlation between hypothyroidism [...] Read more.
Nonalcoholic fatty liver disease (NAFLD) is an emerging worldwide problem and its association with other metabolic pathologies has been one of the main research topics in the last decade. The aim of this review article is to provide an up-to-date correlation between hypothyroidism and NAFLD. We followed evidence regarding epidemiological impact, immunopathogenesis, thyroid hormone-liver axis, lipid and cholesterol metabolism, insulin resistance, oxidative stress, and inflammation. After evaluating the influence of thyroid hormone imbalance on liver structure and function, the latest studies have focused on developing new therapeutic strategies. Thyroid hormones (THs) along with their metabolites and thyroid hormone receptor β (THR-β) agonist are the main therapeutic targets. Other liver specific analogs and alternative treatments have been tested in the last few years as potential NAFLD therapy. Finally, we concluded that further research is necessary as well as the need for an extensive evaluation of thyroid function in NAFLD/NASH patients, aiming for better management and outcome. Full article
(This article belongs to the Special Issue Thyroid Hormones and NAFLD: New Insights)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>The complex relationship of hypothyroidism-induced NAFLD (HIN). Thyroid stimulating hormone (TSH); free thyroxine (fT4); free triiodothyronine (fT3); de novo lipogenesis (DNL); free fatty acids (FFAs); lipoprotein lipase (LPL); triglycerides (TG); AMP-activated protein kinase (AMPK); sterol regulatory element-binding protein (SREBP-1c); tumor necrosis factor alpha (TNF-α).</p>
Full article ">
18 pages, 3801 KiB  
Review
The Significance of Flavonoids in the Process of Biological Nitrogen Fixation
by Wei Dong and Yuguang Song
Int. J. Mol. Sci. 2020, 21(16), 5926; https://doi.org/10.3390/ijms21165926 - 18 Aug 2020
Cited by 49 | Viewed by 6316 | Correction
Abstract
Nitrogen is essential for the growth of plants. The ability of some plant species to obtain all or part of their requirement for nitrogen by interacting with microbial symbionts has conferred a major competitive advantage over those plants unable to do so. The [...] Read more.
Nitrogen is essential for the growth of plants. The ability of some plant species to obtain all or part of their requirement for nitrogen by interacting with microbial symbionts has conferred a major competitive advantage over those plants unable to do so. The function of certain flavonoids (a group of secondary metabolites produced by the plant phenylpropanoid pathway) within the process of biological nitrogen fixation carried out by Rhizobium spp. has been thoroughly researched. However, their significance to biological nitrogen fixation carried out during the actinorhizal and arbuscular mycorrhiza–Rhizobium–legume interaction remains unclear. This review catalogs and contextualizes the role of flavonoids in the three major types of root endosymbiosis responsible for biological nitrogen fixation. The importance of gaining an understanding of the molecular basis of endosymbiosis signaling, as well as the potential of and challenges facing modifying flavonoids either quantitatively and/or qualitatively are discussed, along with proposed strategies for both optimizing the process of nodulation and widening the plant species base, which can support nodulation. Full article
(This article belongs to the Section Biochemistry)
Show Figures

Figure 1

Figure 1
<p>Major branches of the flavonoid biosynthesis pathway. Some of the critical enzymes are abbreviated as follows: CHS, chalcone synthase; DFR, dihydroflavonol 4-reductase; FSI/II, flavone synthase <span class="html-italic">I</span>/<span class="html-italic">II</span>; FLS, flavonol synthase; IFS, isoflavone synthase; IFR, isoflavone reductase; LCR, leucoanthocyanidin reductase; VR, vestitone reductase. Major classes of end-products are emphasized in boxes. This figure was adapted from Ref. [<a href="#B14-ijms-21-05926" class="html-bibr">14</a>].</p>
Full article ">Figure 2
<p>Plant families that participate in intracellular endosymbiosis (<b>A</b>) and the evolution of mutualistic symbiotic associations: a possible scenario (<b>B</b>) (modified from Martin et al., 2017 [<a href="#B20-ijms-21-05926" class="html-bibr">20</a>]); a, arbuscular mycorrhiza-like and/or mucoromycotina associations; b, arbuscular mycorrhiza; c, ectomycorrhiza; d, arbuscular mycorrhiza; e, Frankia N-fixing; f, Rhizobial N-fixing.</p>
Full article ">Figure 3
<p>Nodulation strategies in legume symbionts (modified from Catherine and Joel, 2018 [<a href="#B23-ijms-21-05926" class="html-bibr">23</a>]). In the Nod strategy, strain-specific lipochitin oligosaccharides (LCO) called Nod factors (NFs) are produced under the control of <span class="html-italic">nod</span> genes. NFs are perceived by plant NF receptors that activate the common symbiotic signaling pathway (CSSP). In the T3SS strategy, T3SS effectors activate CSSP components by bypassing NF recognition. The mechanism of the third nodulation strategy is still unknown, but it involves neither <span class="html-italic">nod</span> nor T3SS functions and occurs via CSSP activation.</p>
Full article ">Figure 4
<p>Contrasting cascades for the Nod and T3SS mechanisms.</p>
Full article ">Figure 5
<p>A schematic model of the regulation of auxin transport during nodulation in <span class="html-italic">Medicago truncatula</span>. Before rhizobia infection, auxin is transported in the acropetal direction towards the root tip. Auxin is also transported in the basipetal direction (from root tip to elongation zone) in the outer layer(s). Within 3 h after symbiosis induction (lipochitooligosaccharide treatment), cytokinin biosynthesis is upregulated in the <span class="html-italic">M. truncatula</span> roots [<a href="#B61-ijms-21-05926" class="html-bibr">61</a>]. Cytokinin perception at the inner cortex induces/releases certain flavonoids, which act as inhibitors of acropetal auxin transport at the inner cortical, endodermal and/or pericycle directly underlying the rhizobia infection site [<a href="#B62-ijms-21-05926" class="html-bibr">62</a>]. Flavonoids are auxin transport inhibitors that are thought to disrupt the complex between ABCB1 (ATP-Binding Cassette Subfamily B 1) and TWD1 (TWISTED DWARF1) [<a href="#B63-ijms-21-05926" class="html-bibr">63</a>,<a href="#B64-ijms-21-05926" class="html-bibr">64</a>], affecting transport, and by binding BIG, a protein required for PIN cycling [<a href="#B65-ijms-21-05926" class="html-bibr">65</a>]. The reduction in acropetal auxin transport increases the auxin concentration at the rhizobia infection site, the location of a future nodule primordium. An increase in basipetal auxin transport could also contribute to an increased auxin pool at the nodulation site [<a href="#B62-ijms-21-05926" class="html-bibr">62</a>]. Pericycle, endodermal and cortical cell divisions are activated within 48 h. The red arrow shows the polar auxin transport, and the arrow thickness is proportional to the auxin transport capacity. The green color shows the auxin gradient, and the darker color denotes a higher auxin content. This figure was adapted from Ref. [<a href="#B66-ijms-21-05926" class="html-bibr">66</a>].</p>
Full article ">Figure 6
<p>Schematic overview of flavonoid functions in the process of biological nitrogen fixation.</p>
Full article ">
20 pages, 8064 KiB  
Article
CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood
by Daniëlle Krijgsman, Natasja L. De Vries, Morten N. Andersen, Anni Skovbo, Rob A.E.M. Tollenaar, Holger J. Møller, Marianne Hokland and Peter J.K. Kuppen
Int. J. Mol. Sci. 2020, 21(16), 5925; https://doi.org/10.3390/ijms21165925 - 18 Aug 2020
Cited by 29 | Viewed by 4757
Abstract
The macrophage-associated molecule CD163 has been reported as a prognostic biomarker in different cancer types, but its role in colorectal cancer (CRC) is unclear. We studied CD163 in the tumor microenvironment and circulation of patients with CRC in relation to clinicopathological parameters. An [...] Read more.
The macrophage-associated molecule CD163 has been reported as a prognostic biomarker in different cancer types, but its role in colorectal cancer (CRC) is unclear. We studied CD163 in the tumor microenvironment and circulation of patients with CRC in relation to clinicopathological parameters. An enzyme-linked immunosorbent assay (ELISA) was used to measure the serum sCD163 levels and multiparameter flow cytometry was used to study the peripheral blood monocytes and their CD163 expression in CRC patients (N = 78) and healthy donors (N = 50). The distribution of tumor-associated macrophages (TAMs) was studied in primary colorectal tumors with multiplex immunofluorescence. We showed that CRC patients with above-median sCD163 level had a shorter overall survival (OS, p = 0.035) as well as disease-free survival (DFS, p = 0.005). The above-median sCD163 remained significantly associated with a shorter DFS in the multivariate analysis (p = 0.049). Moreover, a shorter OS was observed in CRC patients with an above-median total monocyte percentage (p = 0.007). The number and phenotype of the stromal and intraepithelial TAMs in colorectal tumors were not associated with clinical outcome. In conclusion, sCD163 and monocytes in the circulation may be potential prognostic biomarkers in CRC patients, whereas TAMs in the tumor showed no association with clinical outcome. Thus, our results emphasize the importance of the innate systemic immune response in CRC disease progression. Full article
(This article belongs to the Collection Feature Papers in Molecular Oncology)
Show Figures

Figure 1

Figure 1
<p>Sample availability for the measurement of monocytes, sCD163 and tumor-associated macrophages (TAMs) in colorectal cancer (CRC) patients and healthy donors. Monocytes, sCD163 and TAMs were studied in 78 CRC patients. TAMs and monocytes were studied in 72 and 47 CRC patients, respectively. Additionally, sCD163 levels were studied in 64 pre-operative and 44 post-operative patients. Finally, monocytes were studied in 10 healthy donors, whereas sCD163 levels were studied in 40 healthy donors. The numbers in the figure indicate the number of patients in each subgroup with overlapping samples. Abbreviations: CRC (colorectal cancer), ELISA (enzyme-linked immunosorbent assay), PBMC (peripheral blood mononuclear cells), sCD163 (soluble CD163), TAM (tumor-associated macrophages).</p>
Full article ">Figure 2
<p>sCD163 levels in the serum of CRC patients and healthy donors as measured by the enzyme-linked immunosorbent assay (ELISA) in relation to clinicopathological parameters. (<b>A</b>) Comparison of sCD163 serum levels in healthy donors (<span class="html-italic">N</span> = 40) and pre-operative CRC patients (<span class="html-italic">N</span> = 64), and the change in sCD163 levels in CRC patients after surgery (<span class="html-italic">N</span> = 39). (<b>B</b>) Association between the sCD163 levels in CRC patients and TNM stage (stage 0/I, <span class="html-italic">N</span> = 15; stage II/III, <span class="html-italic">N</span> = 43; stage IV, <span class="html-italic">N</span> = 6). (<b>C</b>) Association between the sCD163 levels and clinical outcome in CRC patients. Kaplan–Meier curves for the overall survival (OS) are shown for TNM stage 0–IV CRC patients (<span class="html-italic">N</span> = 64) and Kaplan–Meier curves for disease-free survival (DFS) are shown for the TNM stage 0–III CRC patients (N = 58). Stratifications were based on the median sCD163 level (2.0 mg/L). The bars ((<b>A</b>), left figure; (<b>B</b>)) show the median sCD163 level with a 95% confidence interval (CI) whereas the dotted lines show the reference sCD163 levels (0.7–3.9 mg/L). Statistically significant <span class="html-italic">p</span>-values (≤0.05) are indicated in bold. Abbreviations: CI (confidence interval), CRC (colorectal cancer), DFS (disease-free survival), HD (healthy donor), OS (overall survival), sCD163 (soluble CD163), TNM (tumor, node, metastasis).</p>
Full article ">Figure 3
<p>Distribution of monocyte subsets and their level of CD163 expression in the peripheral blood of CRC patients and healthy donors as measured by flow cytometry in relation to clinicopathological parameters (<b>A</b>) Comparison of the total monocyte percentage, monocyte subset distribution (CD14<sup>++</sup>CD16<sup>−</sup> classical, CD14<sup>++</sup>CD16<sup>+</sup> intermediate and CD14<sup>+</sup>CD16<sup>++</sup> nonclassical monocytes), and CD163 expression level on these monocyte subsets between healthy donors (<span class="html-italic">N</span> = 10) and CRC patients (<span class="html-italic">N</span> = 47). (<b>B</b>) Association between the total monocyte percentage and TNM stage (stage 0/I, <span class="html-italic">N</span> = 14; stage II/III, <span class="html-italic">N</span> = 25; stage IV, <span class="html-italic">N</span> = 8), differentiation grade (well/moderate, <span class="html-italic">N</span> = 34; poor, <span class="html-italic">N</span> = 11) and tumor-positive lymph nodes (no, <span class="html-italic">N</span> = 30; yes, <span class="html-italic">N</span> = 17) in CRC patients. (<b>C</b>) Association between the percentage of classical monocytes and differentiation grade (well/moderate, <span class="html-italic">N</span> = 34; poor, <span class="html-italic">N</span> = 11) in CRC patients. (<b>D</b>) Association between the total monocyte percentage and clinical outcome in CRC patients. Kaplan–Meier curves for the OS are shown for TNM stage 0–IV CRC patients (<span class="html-italic">N</span> = 47) and Kaplan–Meier curves for the DFS are shown for stage 0–III CRC patients (<span class="html-italic">N</span> = 39). Stratifications were based on the median total monocyte percentage (24.9%). The bars in figure (<b>A</b>–<b>C</b>) show the median with a 95% CI. Statistically significant <span class="html-italic">p</span>-values (≤0.05) are indicated in bold. Abbreviations: CI (confidence interval), CRC (colorectal cancer), HD (healthy donor), MFI (median fluorescence intensity), PBMCs (peripheral blood mononuclear cells), TNM (tumor, node, metastasis).</p>
Full article ">Figure 4
<p>TAM subsets in primary colorectal tumors as visualized by multiplex immunofluorescence. (<b>A</b>) Image of M0 (CD68<sup>+</sup>iNOS<sup>−</sup>CD163<sup>−</sup>), M1 (CD68<sup>+</sup>iNOS<sup>+</sup>CD163<sup>−</sup>), M2 (CD68<sup>+</sup>iNOS<sup>−</sup>CD163<sup>+</sup>) and M3 (CD68<sup>+</sup>iNOS<sup>+</sup>CD163<sup>+</sup>) TAMs. (<b>B</b>) Representative images of colorectal tumors with high numbers of stromal TAMs (sTAMs) and intraepithelial TAMs (ieTAMs) (white: DAPI; red: cytokeratin<sup>+</sup> tumor epithelium; blue: CD68<sup>+</sup> TAMs). The white arrows indicate examples of TAMs with indicated phenotypes (<b>A</b>) or localizations (<b>B</b>). Abbreviations: CRC (colorectal cancer), iNOS (inducible nitric oxide synthase), ieTAM (intraepithelial TAM), sTAM (stromal TAM), TAM (tumor-associated macrophage).</p>
Full article ">Figure 5
<p>Distribution of the TAM subsets in the stromal and intraepithelial compartments of primary colorectal tumors as measured by multiplex immunofluorescence in relation to clinicopathological parameters. (<b>A</b>) Distribution of the sTAM and ieTAM subsets (CD68<sup>+</sup>iNOS<sup>−</sup>CD163<sup>−</sup> M0, CD68<sup>+</sup>iNOS<sup>+</sup>CD163<sup>−</sup> M1, CD68<sup>+</sup>iNOS<sup>−</sup>CD163<sup>+</sup> M2 and CD68<sup>+</sup>iNOS<sup>+</sup>CD163<sup>+</sup> M3 TAMs) in primary colorectal tumors (<span class="html-italic">N</span> = 72 and <span class="html-italic">N</span> = 68, respectively). (<b>B</b>) Associations between the percentage of M2 ieTAMs and TNM stage (stage 0/I, <span class="html-italic">N</span> = 14; stage II/III, <span class="html-italic">N</span> = 46; stage IV, <span class="html-italic">N</span> = 8), and between the percentage of M2 ieTAMs and M2 ieTAM density and tumor differentiation grade (well/moderate, <span class="html-italic">N</span> = 55; poor, <span class="html-italic">N</span> = 12) in primary colorectal tumors. The bars show the median with a 95% CI. Statistically significant <span class="html-italic">p</span>-values (≤0.05) are indicated in bold. Abbreviations: CI (confidence interval), CRC (colorectal cancer), iNOS (inducible nitric oxide synthase), ieTAM (intraepithelial TAM), sTAM (stromal TAM), TAM (tumor-associated macrophage), TNM (Tumor, Node, Metastasis).</p>
Full article ">
18 pages, 3409 KiB  
Article
Osteoclasts’ Ability to Generate Trenches Rather Than Pits Depends on High Levels of Active Cathepsin K and Efficient Clearance of Resorption Products
by Xenia G. Borggaard, Dinisha C. Pirapaharan, Jean-Marie Delaissé and Kent Søe
Int. J. Mol. Sci. 2020, 21(16), 5924; https://doi.org/10.3390/ijms21165924 - 18 Aug 2020
Cited by 23 | Viewed by 4087
Abstract
Until recently, it was well-accepted that osteoclasts resorb bone according to the resorption cycle model. This model is based on the assumption that osteoclasts are immobile during bone erosion, allowing the actin ring to be firmly attached and thereby provide an effective seal [...] Read more.
Until recently, it was well-accepted that osteoclasts resorb bone according to the resorption cycle model. This model is based on the assumption that osteoclasts are immobile during bone erosion, allowing the actin ring to be firmly attached and thereby provide an effective seal encircling the resorptive compartment. However, through time-lapse, it was recently documented that osteoclasts making elongated resorption cavities and trenches move across the bone surface while efficiently resorbing bone. However, it was also shown that osteoclasts making rounded cavities and pits indeed resorb bone while they are immobile. Only little is known about what distinguishes these two different resorption modes. This is of both basic and clinical interest because these resorption modes are differently sensitive to drugs and are affected by the gender as well as age of the donor. In the present manuscript we show that: 1. levels of active cathepsin K determine the switch from pit to trench mode; 2. pit and trench mode depend on clathrin-mediated endocytosis; and 3. a mechanism integrating release of resorption products and membrane/integrin recycling is required for prolongation of trench mode. Our study therefore contributes to an improved understanding of the molecular and cellular determinants for the two osteoclastic bone resorption modes. Full article
(This article belongs to the Special Issue New Insights in Osteoclasts’ Biology)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Different susceptibilities of pit- and trench-resorbing OCs to distinct types of inhibitors. (<b>a</b>) Representative dose–response curves of bone resorption upon treatment with three different inhibitors. Bone resorption is categorized into pit (black) and trench (red) surface per bone surface. Baseline levels are indicated by black and red circles on the y-axis, respectively. Data represent the results from a single experiment using OCs from a single donor (but different for each drug) and with <span class="html-italic">n</span> = 5 bone slices for each condition tested. %ES/BS, percent eroded surface per bone surface. Error bars represent SD. (<b>b</b>) Linear correlation between the mean trench surface per eroded surface (% TS/ES) (calculated from <span class="html-italic">n</span> = 5 bone slices) in control conditions and the respective IC50 (determined by curve fits as shown for odanacatib in (a)) of odanacatib determined in OC cultures from 14 different donors (each experiment was performed as shown in (a)). (<b>c</b>) Comparison of IC50-values obtained from six different experiments (using different donors) determined for pit surface per bone surface (black) and trench surface per bone surface (red). Data obtained from the same experiment are connected with a line. Each IC50 was determined from individual experiments based on curve fits as shown for chloroquine in (a). Statistics: Wilcoxon paired test. (<b>d</b>) Comparison of pit and trench IC50 values obtained from five different experiments (using different donors) after treatment with Pitstop2. Data obtained from the same experiment are connected with a line. Each IC50 was determined from individual experiments based on curve fits as shown for Pitstop2 in (a). Statistics: Wilcoxon paired test, <span class="html-italic">n</span> = 5. (<b>e</b>) Comparison of percentwise inhibition at the highest dose of Pitstop2 with respect to pit and trench surfaces obtained from six different experiments (using different donors). Data obtained from the same experiment are connected with a line. Each level of inhibition was determined from individual experiments based on curve fits as shown for Pitstop2 in (a). Statistics: Wilcoxon paired test.</p>
Full article ">Figure 2
<p>Chloroquine, at 10 or 20 µM, does not reduce the demineralization depth of pits or trenches, but significantly reduces the length of trenches. (<b>a</b>) Representative analysis of depth from one resorption experiment (using OCs from a single donor) subdivided into pits and trenches. Each point represents the mean of 100 analyzed events per bone slice (<span class="html-italic">n</span> = 5 bone slices per condition). Statistics: Kruskal–Wallis test. (<b>b</b>) Median depth of pits and trenches in three different experiments with OCs from different donors. These medians were determined from five bone slices per condition as shown in (a). Statistics: Friedmann test. (<b>c</b>) Representative analysis of trench length from one resorption experiment (using OCs from a single donor); each point represents the mean of 100 events per bone slice (<span class="html-italic">n</span> = 5 bone slices per condition). Statistics: Kruskal–Wallis test. (<b>d</b>) Median length of trenches in three different experiments with OCs from different donors. These medians were determined from five bone slices per condition as shown in (c). Statistics: Friedmann test.</p>
Full article ">Figure 3
<p>Time-lapse analyses document that 10 µM chloroquine makes trench-forming OCs stop prematurely. Representative images selected from one 70 h time-lapse recording. (<b>a</b>) Images from control condition (<a href="#app1-ijms-21-05924" class="html-app">Supplementary Materials Movie 1</a>) showing selected time-lapse images out of 70 h total recording time. The images show an OC making a pit and subsequently switching into trench formation. The width of each image is 122.6 µm. (<b>b</b>) Images from the chloroquine condition (10 µM chloroquine added 4 h prior to start of recording, <a href="#app1-ijms-21-05924" class="html-app">Supplementary Materials Movie 2</a>), showing selected time-lapse images from a total recording of 70 h. The images show an OC making a pit and subsequently switching into trench formation. The width of each image is 176.4 µm. (<b>c</b>) Kymograph analysis of the control OC shown in (a) and <a href="#app1-ijms-21-05924" class="html-app">Supplementary Materials Movie 1</a> showing SiR-actin or rhodamine signals throughout the time-lapse recording. The upper images show the trace line (yellow) that reflects movement of the OC (left) or the resorption front (right) over time and along which the fluorescent intensities are measured. The images reflect the end stage of the time-lapse recording. The lower images show the kymographs reflecting the intensity of f-actin or rhodamine over time along the yellow line. The absence of accumulated rhodamine signal in the OC is marked by an orange arrow. (<b>d</b>) Kymograph analysis of the chloroquine treated OC shown in (b) and <a href="#app1-ijms-21-05924" class="html-app">Supplementary Materials Movie 2</a> showing SiR-actin or rhodamine signals throughout the time-lapse recording. The upper images show the trace line (yellow) that reflects movement of the OC (left) or the resorption front (right) over time and along which the fluorescent intensities are measured. The images reflect the end stage of the time-lapse recording. The lower images show the kymographs reflecting the intensity of f-actin or rhodamine over time along the yellow line. The time point where the front of the resorbing OC detaches and resorption stops is marked by a narrow yellow dotted line. The accumulation of rhodamine signal in the OC just prior to termination of bone resorption is marked by an orange arrow.</p>
Full article ">Figure 4
<p>Quantification of time-lapse recording: Chloroquine (10 µM) reduces the duration of resorption but not the speed of OCs making trenches; OCs making pits are unaffected, illustrated by data obtained from time-lapse recordings with OCs from a single donor. (<b>a</b>) Relation between length of trench and time of active resorption for all trenches identified in one experiment, subdivided into control (CTRL; green; <span class="html-italic">n</span> = 47) with a linear regression fit of <span class="html-italic">r</span><sup>2</sup> = 0.65 and <span class="html-italic">p</span> &lt; 0.0001 and chloroquine-treated (CQ; black; <span class="html-italic">n</span> = 20) with a linear regression fit of <span class="html-italic">r</span><sup>2</sup> = 0.57 and <span class="html-italic">p</span> = 0.0001. Slopes and y-intercepts of both linear regression fits were tested and found not to be different (<span class="html-italic">p</span> = 0.6738 and <span class="html-italic">p</span> = 0.9678, respectively) (<b>b</b>) Diagram visualizing the timeframes of active resorption for individual OCs making trenches, subdivided into control (green; <span class="html-italic">n</span> = 45) and chloroquine-treated (black; <span class="html-italic">n</span> = 18). (<b>c</b>) Pie chart showing the percentage of trench-making OCs that stop resorption during time-lapse recording (grey) compared to those that continue throughout recording in control (green) and chloroquine (grey) conditions. Statistics: Fishers exact test (<span class="html-italic">p</span> = 0.0376). (<b>d</b>) Relation between diameter of pits and time of active resorption for all pits identified in one experiment, subdivided into control (green; <span class="html-italic">n</span> = 86) with a linear regression fit of <span class="html-italic">r</span><sup>2</sup> = 0.28 and <span class="html-italic">p</span> &lt; 0.0001 and chloroquine-treated (black: <span class="html-italic">n</span> = 31) with a linear regression fit of r<sup>2</sup> = 0.40 and <span class="html-italic">p</span> &lt; 0.0001. Slopes and y-intercepts of both linear regression fits were tested and found not to be different (<span class="html-italic">p</span> = 0.9075 and <span class="html-italic">p</span> = 0.0622, respectively). (<b>e</b>) Active resorption time for all pits identified in one experiment for control (green; <span class="html-italic">n</span> = 91) and chloroquine (black; <span class="html-italic">n</span> = 32). Statistics: Mann–Whitney test (<span class="html-italic">p</span> = 0.9999).</p>
Full article ">Figure 5
<p>Time-lapse recording reveal that cathepsin D positive lysosomes show different abundance and transportation in OCs making trenches and pits. Images are selected snapshots from <a href="#app1-ijms-21-05924" class="html-app">Supplementary Materials Movie 3</a> showing a 70 h time-lapse recording of resorbing OCs labelled with SiR700-Lysosome Tracker on rhodamine coated bovine bone slices. (<b>a</b>) An OC initially making a pit (yellow circle) and subsequently switching into trench mode resorption. Orange arrows indicate the resorption front while the orange arrow-head highlights where the lysosomes are transported to at the rear end of the OC. The width of each image is 72.4 µm. (<b>b</b>) An OC only making a pit. Cathepsin D-positive vesicles are distributed equally within the boundaries of the cavity (yellow circle) without any signs of polarization. The width of each image is 56.6 µm.</p>
Full article ">Figure 6
<p>Chloroquine accumulates towards the rear end of trench-making OCs. Chloroquine immunoreactivity is shown in red, f-actin in blue, and tubulin in green. Upper and lower images are views looking down on the OC from above the bone surface, whereas the center image shows a longitudinal cross-section of the same OC. Dashed white lines show the edge of the resorption cavity (top and bottom images), while it shows the bone surface in the center image. The width of all three images is 141.4 µm.</p>
Full article ">Figure 7
<p>Chloroquine seems to cause an enlargement of acridine orange stained vesicles in OCs making trenches. (<b>a</b>) A 3D confocal view of trench-forming OC in the control condition. (<b>b</b>) A 3D confocal view of a trench-forming OC treated with 10 µM chloroquine. Circumference of OCs are indicated by a green dashed line, while the edge of the resorptive cavities is shown with a white dashed line. The direction of resorption is indicated with an arrow. Acridine orange turns red/orange in acidic compartments, while in more neutral compartments it is green. The white bars represent 20 µm.</p>
Full article ">Figure 8
<p>Model illustrating the unique features of the trench resorption mode demonstrated in the present study. Grey symbols represent three nuclei. Please refer to Discussion for further details.</p>
Full article ">
25 pages, 9171 KiB  
Article
Oxidant-Induced Alterations in the Adipocyte Transcriptome: Role of the Na,K-ATPase Oxidant Amplification Loop
by Komal Sodhi, James Denvir, Jiang Liu, Juan R. Sanabria, Yiliang Chen, Roy Silverstein, Zijian Xie, Nader G. Abraham and Joseph I. Shapiro
Int. J. Mol. Sci. 2020, 21(16), 5923; https://doi.org/10.3390/ijms21165923 - 18 Aug 2020
Cited by 7 | Viewed by 2783
Abstract
(1) Background: Recently we have noted that adipocyte specific expression of the peptide, NaKtide, which was developed to attenuate the Na,K-ATPase oxidant amplification loop, could ameliorate the phenotypical features of uremic cardiomyopathy. We performed this study to better characterize the cellular transcriptomes that [...] Read more.
(1) Background: Recently we have noted that adipocyte specific expression of the peptide, NaKtide, which was developed to attenuate the Na,K-ATPase oxidant amplification loop, could ameliorate the phenotypical features of uremic cardiomyopathy. We performed this study to better characterize the cellular transcriptomes that are involved in various biological pathways associated with adipocyte function occurring with renal failure. (2) Methods: RNAseq was performed on the visceral adipose tissue of animals subjected to partial nephrectomy. Specific expression of NaKtide in adipocytes was achieved using an adiponectin promoter. To better understand the cause of gene expression changes in vivo, 3T3L1 adipocytes were exposed to indoxyl sulfate (IS) or oxidized low density lipoprotein (oxLDL), with and without pNaKtide (the cell permeant form of NaKtide). RNAseq was also performed on these samples. (3) Results: We noted a large number of adipocyte genes were altered in experimental renal failure. Adipocyte specific NaKtide expression reversed most of these abnormalities. High correlation with some cardiac specific phenotypical features was noted amongst groups of these genes. In the murine adipocytes, both IS and oxLDL induced similar pathway changes as were noted in vivo, and pNaKtide appeared to reverse these changes. Network analysis demonstrated tremendous similarities between the network revealed by gene expression analysis with IS compared with oxLDL, and the combined in vitro dataset was noted to also have considerable similarity to that seen in vivo with experimental renal failure. (4) Conclusions: This study suggests that the myriad of phenotypical features seen with experimental renal failure may be fundamentally linked to oxidant stress within adipocytes. Full article
(This article belongs to the Special Issue Cardiotonic Steroids: From Toxins to Hormones)
Show Figures

Figure 1

Figure 1
<p>(<b>A</b>) Volcano plots of gene expression in PNx vs. Control (left panel) and PNx + NaKtide vs. PNx (right panel) plotting antilog of unadjusted <span class="html-italic">p</span>-value on y-axis vs. log<sub>2</sub> Fold Change on x-axis. Genes downregulated (unadjusted <span class="html-italic">p</span>-value of &lt;0.1) by PNx colored orange and genes upregulated (unadjusted <span class="html-italic">p</span>-value of &lt;0.1) by PNx colored blue. We note that addition of NaKtide expression moved upregulated genes down and downregulated genes up. (<b>B</b>) Heat map of gene expression in top 100 up and 100 downregulated genes with PNx. Color coding based on log<sub>2</sub> Fold Change with legend shown below. We note little difference between NaKtide and Control, but the addition of NaKtide to PNx appears to normalize both up and downregulated gene expression. (<b>C</b>) Gene Ontology summary of over representation analysis (ORA) in PNx mice model. Gene ontology annotation of biological processes, cellular components and molecular function categories. (<b>D</b>) Reactome ORA of differentially expressed genes in PNx mice model. The scatter dot plot of reactome enrichment representing the number of differentially expressed genes enriched in GO terms. <span class="html-italic">p</span>-value and gene ratio (number of differentially expressed genes in GO term)/(total number of genes in GO term) are shown in the plot. Larger circles indicate more enriched genes.</p>
Full article ">Figure 1 Cont.
<p>(<b>A</b>) Volcano plots of gene expression in PNx vs. Control (left panel) and PNx + NaKtide vs. PNx (right panel) plotting antilog of unadjusted <span class="html-italic">p</span>-value on y-axis vs. log<sub>2</sub> Fold Change on x-axis. Genes downregulated (unadjusted <span class="html-italic">p</span>-value of &lt;0.1) by PNx colored orange and genes upregulated (unadjusted <span class="html-italic">p</span>-value of &lt;0.1) by PNx colored blue. We note that addition of NaKtide expression moved upregulated genes down and downregulated genes up. (<b>B</b>) Heat map of gene expression in top 100 up and 100 downregulated genes with PNx. Color coding based on log<sub>2</sub> Fold Change with legend shown below. We note little difference between NaKtide and Control, but the addition of NaKtide to PNx appears to normalize both up and downregulated gene expression. (<b>C</b>) Gene Ontology summary of over representation analysis (ORA) in PNx mice model. Gene ontology annotation of biological processes, cellular components and molecular function categories. (<b>D</b>) Reactome ORA of differentially expressed genes in PNx mice model. The scatter dot plot of reactome enrichment representing the number of differentially expressed genes enriched in GO terms. <span class="html-italic">p</span>-value and gene ratio (number of differentially expressed genes in GO term)/(total number of genes in GO term) are shown in the plot. Larger circles indicate more enriched genes.</p>
Full article ">Figure 2
<p>(<b>A</b>) Network dendrogram and trait heat map. Hierarchical clustering of treatment groups that summarize the modules found in the clustering analysis. Branches of the dendrogram cluster together into treatment groups that are positively correlated. Heat map displays correlation between different parameters analyzed. (<b>B</b>) Scale independence and mean connectivity as a function of soft threshold in PNx model. Based on these data, we chose a soft threshold (power) of 20 to construct the network(s) described in subsequent figures. (<b>C</b>) Dendrogram and group assignments produced from network generation on gene expression derived from in vivo experiment. Network produced using R package WGCNA where data on dendrogram represents distance metric (1-Pearson coefficient). Genes clustered according to a topological overlap metric into modules; assigned modules are colored at the bottom, gray genes are unassigned to a module. (<b>D</b>) Module-trait relationships of different parameters analyzed and major pathways associated with cardiac phenotype. Each row in the table (right panel) corresponds to different gene groupings, and each column to selected cardiac phenotypical features. Based on the highest correlations with these 5 phenotypical features (myocardial performance index (MPI), relative wall thickness (RWT), ejection fraction (EF), left ventricular mass (LVM) and cardiac fibrosis (CF)), five groups of genes were further analyzed for ORA against the KEGG database (left panel).</p>
Full article ">Figure 2 Cont.
<p>(<b>A</b>) Network dendrogram and trait heat map. Hierarchical clustering of treatment groups that summarize the modules found in the clustering analysis. Branches of the dendrogram cluster together into treatment groups that are positively correlated. Heat map displays correlation between different parameters analyzed. (<b>B</b>) Scale independence and mean connectivity as a function of soft threshold in PNx model. Based on these data, we chose a soft threshold (power) of 20 to construct the network(s) described in subsequent figures. (<b>C</b>) Dendrogram and group assignments produced from network generation on gene expression derived from in vivo experiment. Network produced using R package WGCNA where data on dendrogram represents distance metric (1-Pearson coefficient). Genes clustered according to a topological overlap metric into modules; assigned modules are colored at the bottom, gray genes are unassigned to a module. (<b>D</b>) Module-trait relationships of different parameters analyzed and major pathways associated with cardiac phenotype. Each row in the table (right panel) corresponds to different gene groupings, and each column to selected cardiac phenotypical features. Based on the highest correlations with these 5 phenotypical features (myocardial performance index (MPI), relative wall thickness (RWT), ejection fraction (EF), left ventricular mass (LVM) and cardiac fibrosis (CF)), five groups of genes were further analyzed for ORA against the KEGG database (left panel).</p>
Full article ">Figure 3
<p>KEGG pathway analysis and validation of RNAseq data in visceral adipose tissue of PNx mice model with alteration of key genes associated with Na,K-ATPase signaling pathway. (<b>A</b>) PNx vs. Control (<b>B</b>) PNx + NaKtide vs. PNx. NaKtide administration to PNx appears to normalize both up and downregulated gene expression. Blue represents genes upregulated and orange represents genes downregulated. (<b>C</b>) Comparative gene expression analysis was done for eight representative genes selected from Na,K-ATPase signaling pathway from transcriptomic data and qRT-PCR. Results are expressed as log<sub>2</sub> values of the fold change.</p>
Full article ">Figure 3 Cont.
<p>KEGG pathway analysis and validation of RNAseq data in visceral adipose tissue of PNx mice model with alteration of key genes associated with Na,K-ATPase signaling pathway. (<b>A</b>) PNx vs. Control (<b>B</b>) PNx + NaKtide vs. PNx. NaKtide administration to PNx appears to normalize both up and downregulated gene expression. Blue represents genes upregulated and orange represents genes downregulated. (<b>C</b>) Comparative gene expression analysis was done for eight representative genes selected from Na,K-ATPase signaling pathway from transcriptomic data and qRT-PCR. Results are expressed as log<sub>2</sub> values of the fold change.</p>
Full article ">Figure 4
<p>(<b>A</b>) Volcano plots of gene expression in adipocytes exposed to oxLDL (Ox) vs. control (CTL) (left panel) and oxLDL+ pNaKtide (OxP) vs. oxLDL (Ox) expression (right panel) plotting antilog of unadjusted <span class="html-italic">p</span>-value on y-axis vs. log<sub>2</sub> Fold Change on x-axis. Genes downregulated (unadjusted <span class="html-italic">p</span>-value &lt; 0.1) by oxLDL colored orange and genes upregulated (unadjusted <span class="html-italic">p</span>-value of &lt;0.1) by oxLDL colored blue. We note that addition of pNaKtide expression moved upregulated genes down and downregulated genes up. (<b>B</b>) Gene Ontology summary of over representation analysis (ORA) in oxLDL treated murine adipocytes. Gene ontology annotation of biological processes, cellular components and molecular function categories. (<b>C</b>) Reactome ORA of differentially expressed genes in oxLDL treated murine adipocytes. The scatter dot plot of reactome enrichment representing the number of differentially expressed genes enriched in GO terms.</p>
Full article ">Figure 5
<p>(<b>A</b>) Volcano plot of gene expression in adipocytes exposed to IS vs. control (CTL) (left panel) and IS+ pNaKtide (ISP) vs. IS expression (right panel) plotting antilog of unadjusted <span class="html-italic">p</span>-value on y-axis vs. log<sub>2</sub> Fold Change on x-axis. Genes downregulated (unadjusted <span class="html-italic">p</span>-value of &lt;0.1) by IS colored orange and genes upregulated (unadjusted <span class="html-italic">p</span>-value of &lt;0.1) by IS colored blue. We note that addition of pNaKtide expression moved upregulated genes down and downregulated genes up. (<b>B</b>) Gene Ontology summary of over representation analysis (ORA) in IS treated murine adipocytes. Gene ontology annotation of biological processes, cellular components and molecular function categories.</p>
Full article ">Figure 6
<p>Pathway enrichment analysis using genes differentially expressed in vitro and in vivo in response to oxidative stress. The in vitro (oxLDL and IS treatment) and in vivo (PNx mouse model) response to oxidative stress differs in pathway enrichment, but some pathways overlap. The Venn diagram depicts the overlap of all enriched pathways among in vitro and in vivo, with selected common pathways (15 most relevant) and their BH-adjusted <span class="html-italic">p</span>-values depicted adjacent to the Venn diagram. Enriched pathways with little relevance to adipocyte biology have been omitted for clarity. Overlap of common pathways between (<b>A</b>) IS treatment and PNx mouse model, (<b>B</b>) oxLDL treatment and PNx mouse model, (<b>C</b>) IS and oxLDL treatment, and (<b>D</b>) in vitro (IS and oxLDL treatment) and in vivo (PNx mouse model).</p>
Full article ">Figure 6 Cont.
<p>Pathway enrichment analysis using genes differentially expressed in vitro and in vivo in response to oxidative stress. The in vitro (oxLDL and IS treatment) and in vivo (PNx mouse model) response to oxidative stress differs in pathway enrichment, but some pathways overlap. The Venn diagram depicts the overlap of all enriched pathways among in vitro and in vivo, with selected common pathways (15 most relevant) and their BH-adjusted <span class="html-italic">p</span>-values depicted adjacent to the Venn diagram. Enriched pathways with little relevance to adipocyte biology have been omitted for clarity. Overlap of common pathways between (<b>A</b>) IS treatment and PNx mouse model, (<b>B</b>) oxLDL treatment and PNx mouse model, (<b>C</b>) IS and oxLDL treatment, and (<b>D</b>) in vitro (IS and oxLDL treatment) and in vivo (PNx mouse model).</p>
Full article ">Figure 7
<p>Network diagram associated with major pathways by GSEA altered in vitro. Color coding based on log<sub>2</sub> Fold Change with legend shown above. All genes were identified in KEGG pathways and are therefore associated with other genes in the STRING database.</p>
Full article ">Figure 8
<p>(<b>A</b>) Consensus network from in vitro experiments involving exposure to IS or oxLDL. Gene dendrogram obtained by average linkage hierarchical clustering for in vitro (IS and oxLDL) treatments. Gene expression similarity was determined using a pair-wise weighted correlation metric, and clustered according to a topological overlap metric into modules; assigned modules are colored at the bottom, gray genes are unassigned to a module. (<b>B</b>) Summary plot of consensus eigengene networks and their differential analysis from IS and oxLDL datasets. Top panels show clustering of consensus eigengenes in IS and oxLDL groups. Next, heat maps show high (red) and low (or negative, green) adjacency. Preservation heat map is 1-absolute difference of the eigengene networks in the two sets. Bar plot shows mean preservation of adjacency for each eigengene to other eigengenes with a D value calculated as the arithmetic mean of these measurements. (<b>C</b>) Consensus network from in vivo (PNx model) and in vitro experiments (both IS and oxLDL datasets). Gene dendrogram obtained by average linkage hierarchical clustering for in vivo and in vitro experiments. Gene expression similarity was determined using a pair-wise weighted correlation metric, and clustered according to a topological overlap metric into modules; assigned modules are colored at the bottom, gray genes are unassigned to a module. (<b>D</b>) Summary plot of consensus eigengene networks and their differential analysis from in vivo and in vitro (both IS and oxLDL) datasets. Top panels show clustering of consensus eigengenes in the two groups. Next, heat maps show high (red) and low (or negative, green) adjacency. Preservation heat map is 1-absolute difference of the eigengene networks in the two sets. Bar plot shows mean preservation of adjacency for each eigengene to other eigengenes with a D value calculated as the arithmetic mean of these measurements.</p>
Full article ">Figure 8 Cont.
<p>(<b>A</b>) Consensus network from in vitro experiments involving exposure to IS or oxLDL. Gene dendrogram obtained by average linkage hierarchical clustering for in vitro (IS and oxLDL) treatments. Gene expression similarity was determined using a pair-wise weighted correlation metric, and clustered according to a topological overlap metric into modules; assigned modules are colored at the bottom, gray genes are unassigned to a module. (<b>B</b>) Summary plot of consensus eigengene networks and their differential analysis from IS and oxLDL datasets. Top panels show clustering of consensus eigengenes in IS and oxLDL groups. Next, heat maps show high (red) and low (or negative, green) adjacency. Preservation heat map is 1-absolute difference of the eigengene networks in the two sets. Bar plot shows mean preservation of adjacency for each eigengene to other eigengenes with a D value calculated as the arithmetic mean of these measurements. (<b>C</b>) Consensus network from in vivo (PNx model) and in vitro experiments (both IS and oxLDL datasets). Gene dendrogram obtained by average linkage hierarchical clustering for in vivo and in vitro experiments. Gene expression similarity was determined using a pair-wise weighted correlation metric, and clustered according to a topological overlap metric into modules; assigned modules are colored at the bottom, gray genes are unassigned to a module. (<b>D</b>) Summary plot of consensus eigengene networks and their differential analysis from in vivo and in vitro (both IS and oxLDL) datasets. Top panels show clustering of consensus eigengenes in the two groups. Next, heat maps show high (red) and low (or negative, green) adjacency. Preservation heat map is 1-absolute difference of the eigengene networks in the two sets. Bar plot shows mean preservation of adjacency for each eigengene to other eigengenes with a D value calculated as the arithmetic mean of these measurements.</p>
Full article ">Figure 8 Cont.
<p>(<b>A</b>) Consensus network from in vitro experiments involving exposure to IS or oxLDL. Gene dendrogram obtained by average linkage hierarchical clustering for in vitro (IS and oxLDL) treatments. Gene expression similarity was determined using a pair-wise weighted correlation metric, and clustered according to a topological overlap metric into modules; assigned modules are colored at the bottom, gray genes are unassigned to a module. (<b>B</b>) Summary plot of consensus eigengene networks and their differential analysis from IS and oxLDL datasets. Top panels show clustering of consensus eigengenes in IS and oxLDL groups. Next, heat maps show high (red) and low (or negative, green) adjacency. Preservation heat map is 1-absolute difference of the eigengene networks in the two sets. Bar plot shows mean preservation of adjacency for each eigengene to other eigengenes with a D value calculated as the arithmetic mean of these measurements. (<b>C</b>) Consensus network from in vivo (PNx model) and in vitro experiments (both IS and oxLDL datasets). Gene dendrogram obtained by average linkage hierarchical clustering for in vivo and in vitro experiments. Gene expression similarity was determined using a pair-wise weighted correlation metric, and clustered according to a topological overlap metric into modules; assigned modules are colored at the bottom, gray genes are unassigned to a module. (<b>D</b>) Summary plot of consensus eigengene networks and their differential analysis from in vivo and in vitro (both IS and oxLDL) datasets. Top panels show clustering of consensus eigengenes in the two groups. Next, heat maps show high (red) and low (or negative, green) adjacency. Preservation heat map is 1-absolute difference of the eigengene networks in the two sets. Bar plot shows mean preservation of adjacency for each eigengene to other eigengenes with a D value calculated as the arithmetic mean of these measurements.</p>
Full article ">
18 pages, 3375 KiB  
Article
The Role of Atypical Cannabinoid Ligands O-1602 and O-1918 on Skeletal Muscle Homeostasis with a Focus on Obesity
by Anna C. Simcocks, Lannie O’Keefe, Kayte A. Jenkin, Lauren M. Cornall, Esther Grinfeld, Michael L. Mathai, Deanne H. Hryciw and Andrew J. McAinch
Int. J. Mol. Sci. 2020, 21(16), 5922; https://doi.org/10.3390/ijms21165922 - 18 Aug 2020
Cited by 11 | Viewed by 3313
Abstract
O-1602 and O-1918 are atypical cannabinoid ligands for GPR55 and GPR18, which may be novel pharmaceuticals for the treatment of obesity by targeting energy homeostasis regulation in skeletal muscle. This study aimed to determine the effect of O-1602 or O-1918 on markers of [...] Read more.
O-1602 and O-1918 are atypical cannabinoid ligands for GPR55 and GPR18, which may be novel pharmaceuticals for the treatment of obesity by targeting energy homeostasis regulation in skeletal muscle. This study aimed to determine the effect of O-1602 or O-1918 on markers of oxidative capacity and fatty acid metabolism in the skeletal muscle. Diet-induced obese (DIO) male Sprague Dawley rats were administered a daily intraperitoneal injection of O-1602, O-1918 or vehicle for 6 weeks. C2C12 myotubes were treated with O-1602 or O-1918 and human primary myotubes were treated with O-1918. GPR18 mRNA was expressed in the skeletal muscle of DIO rats and was up-regulated in red gastrocnemius when compared with white gastrocnemius. O-1602 had no effect on mRNA expression on selected markers for oxidative capacity, fatty acid metabolism or adiponectin signalling in gastrocnemius from DIO rats or in C2C12 myotubes, while APPL2 mRNA was up-regulated in white gastrocnemius in DIO rats treated with O-1918. In C2C12 myotubes treated with O-1918, PGC1α, NFATc1 and PDK4 mRNA were up-regulated. There were no effects of O-1918 on mRNA expression in human primary myotubes derived from obese and obese T2DM individuals. In conclusion, O-1602 does not alter mRNA expression of key pathways important for skeletal muscle energy homeostasis in obesity. In contrast, O-1918 appears to alter markers of oxidative capacity and fatty acid metabolism in C2C12 myotubes only. GPR18 is expressed in DIO rat skeletal muscle and future work could focus on selectively modulating GPR18 in a tissue-specific manner, which may be beneficial for obesity-targeted therapies. Full article
(This article belongs to the Special Issue Peripheral Targets in Obesity: Pathologies and Therapeutics)
Show Figures

Figure 1

Figure 1
<p>The abundance of mRNA expressed for G Protein-Coupled Receptor 18 and markers involved in adiponectin signalling, fatty acid metabolism and oxidative capacity in red gastrocnemius skeletal muscle obtained from rats fed a high fat diet for 9 weeks to induce obesity. The diet induced obese (DIO) control rats, the DIO O-1602 rats and the DIO O-1918 rats were treated via intraperitoneal injection for a further 6 weeks. mRNA expression was normalised to the average of housekeeping genes cyclophilin and βActin and grouped data is reported as mean (arbitrary units) ± SEM. <a href="#ijms-21-05922-f001" class="html-fig">Figure 1</a>a The red gastrocnemius treatment groups compared to the white gastrocnemius group (* significance <span class="html-italic">p</span> &lt; 0.05). <a href="#ijms-21-05922-f001" class="html-fig">Figure 1</a>b–i The DIO control group is compared to either the DIO O-1602 group or the DIO O-1918 group. (<b>a</b>) G Protein-Coupled Receptor 18 (includes both DIO red and white gastrocnemius); (<b>b</b>) Adiponectin Receptor 1 (AdipoR1); (<b>c</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 1 (APPL1); (<b>d</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 2 (APPL2); (<b>e</b>) Peroxisome proliferator-activated receptor gamma co-activator 1 alpha (PGC1α); (<b>f</b>) Forkhead box protein 01 (FOXO1); (<b>g</b>) Fatty Acid Translocase/Cluster of Differentiation 36 (FATCD/36); (<b>h</b>) beta-hydroxyacyl-CoA dehydrogenase (βHAD); (<b>i</b>) Pyruvate Dehydrogenase Kinase 4 (PDK4).</p>
Full article ">Figure 1 Cont.
<p>The abundance of mRNA expressed for G Protein-Coupled Receptor 18 and markers involved in adiponectin signalling, fatty acid metabolism and oxidative capacity in red gastrocnemius skeletal muscle obtained from rats fed a high fat diet for 9 weeks to induce obesity. The diet induced obese (DIO) control rats, the DIO O-1602 rats and the DIO O-1918 rats were treated via intraperitoneal injection for a further 6 weeks. mRNA expression was normalised to the average of housekeeping genes cyclophilin and βActin and grouped data is reported as mean (arbitrary units) ± SEM. <a href="#ijms-21-05922-f001" class="html-fig">Figure 1</a>a The red gastrocnemius treatment groups compared to the white gastrocnemius group (* significance <span class="html-italic">p</span> &lt; 0.05). <a href="#ijms-21-05922-f001" class="html-fig">Figure 1</a>b–i The DIO control group is compared to either the DIO O-1602 group or the DIO O-1918 group. (<b>a</b>) G Protein-Coupled Receptor 18 (includes both DIO red and white gastrocnemius); (<b>b</b>) Adiponectin Receptor 1 (AdipoR1); (<b>c</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 1 (APPL1); (<b>d</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 2 (APPL2); (<b>e</b>) Peroxisome proliferator-activated receptor gamma co-activator 1 alpha (PGC1α); (<b>f</b>) Forkhead box protein 01 (FOXO1); (<b>g</b>) Fatty Acid Translocase/Cluster of Differentiation 36 (FATCD/36); (<b>h</b>) beta-hydroxyacyl-CoA dehydrogenase (βHAD); (<b>i</b>) Pyruvate Dehydrogenase Kinase 4 (PDK4).</p>
Full article ">Figure 2
<p>The abundance of mRNA expressed for markers involved in adiponectin signalling, fatty acid metabolism and oxidative capacity in white gastrocnemius skeletal muscle obtained from rats fed a high fat diet for 9 weeks to induce obesity. The DIO control rats, DIO O-1602 rats and the DIO O-1918 rats were treated via intraperitoneal injection for a further 6 weeks. mRNA expression was normalised to the average of housekeeping genes cyclophilin and βActin and grouped data is reported as mean (arbitrary units) ± SEM. The DIO control group is compared to either the DIO O-1602 group (* significance <span class="html-italic">p</span> &lt; 0.05) or the DIO O-1918 group (* significance <span class="html-italic">p</span> &lt; 0.05). (<b>a</b>) Adiponectin Receptor 1 (AdipoR1); (<b>b</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 1 (APPL1); (<b>c</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 2 (APPL2); (<b>d</b>) Forkhead box protein 01 (FOXO1); (<b>e</b>) Peroxisome proliferator-activated receptor gamma co-activator 1 alpha (PGC1α); (<b>f</b>) beta-hydroxyacyl-CoA dehydrogenase (βHAD); (<b>g</b>) Fatty Acid Translocase/Cluster of Differentiation 36 (FATCD/36); (<b>h</b>) Pyruvate Dehydrogenase Kinase 4 (PDK4).</p>
Full article ">Figure 3
<p>The abundance of mRNA expressed for markers involved in adiponectin signalling, fatty acid oxidation and oxidative capacity in C<sub>2</sub>C<sub>12</sub> myotubes treated for 24 h with O-1602 (10–1000 nM). mRNA expression was normalised to housekeeping gene Hypoxanthine Phosphoribosyltransferase (HPRT1) and grouped data is reported as mean (arbitrary units) ± SEM. (<b>a</b>) Nuclear Factor of Activated T-Cells calcineurin dependent 1 (NFATc1); (<b>b</b>) Peroxisome proliferator-activated receptor gamma co activator 1-alpha (PGC1α); (<b>c</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 1 (APPL1); (<b>d</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 2 (APPL2).</p>
Full article ">Figure 4
<p>The abundance of mRNA expressed for markers involved in adiponectin signalling, fatty acid oxidation and oxidative capacity in C<sub>2</sub>C<sub>12</sub> myotubes treated for 24 h with O-1918 (100 nM). mRNA expression was normalised to housekeeping gene Hypoxanthine Phosphoribosyltransferase (HPRT1) and grouped data is reported as mean (arbitrary units) ± SEM (* significance <span class="html-italic">p</span> &lt; 0.05). (<b>a</b>) Nuclear Factor of Activated T-Cells calcineurin dependent 1 (NFATc1); (<b>b</b>) Peroxisome proliferator-activated receptor gamma co activator 1-alpha (PGC1α); (<b>c</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 1 (APPL1); (<b>d</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 2 (APPL2); (<b>e</b>) Adenosine Monophosphate Kinase alpha 2 (AMPKα2); (<b>f</b>) Pyruvate Dehydrogenase Kinase 4 (PDK4).</p>
Full article ">Figure 4 Cont.
<p>The abundance of mRNA expressed for markers involved in adiponectin signalling, fatty acid oxidation and oxidative capacity in C<sub>2</sub>C<sub>12</sub> myotubes treated for 24 h with O-1918 (100 nM). mRNA expression was normalised to housekeeping gene Hypoxanthine Phosphoribosyltransferase (HPRT1) and grouped data is reported as mean (arbitrary units) ± SEM (* significance <span class="html-italic">p</span> &lt; 0.05). (<b>a</b>) Nuclear Factor of Activated T-Cells calcineurin dependent 1 (NFATc1); (<b>b</b>) Peroxisome proliferator-activated receptor gamma co activator 1-alpha (PGC1α); (<b>c</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 1 (APPL1); (<b>d</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 2 (APPL2); (<b>e</b>) Adenosine Monophosphate Kinase alpha 2 (AMPKα2); (<b>f</b>) Pyruvate Dehydrogenase Kinase 4 (PDK4).</p>
Full article ">Figure 5
<p>The abundance of mRNA expressed for markers involved in adiponectin signalling and oxidative capacity in human primary <span class="html-italic">rectus abdominus</span>-derived myotubes obtained from individuals that are obese treated for 24 h with O-1918 (25–200 nM). mRNA expression was normalised to housekeeping gene Cyclophilin and grouped data is reported as mean (arbitrary units) ± SEM. (<b>a</b>) Nuclear Factor of Activated T-Cells calcineurin dependent 1 (NFATc1); (<b>b</b>) Peroxisome proliferator-activated receptor gamma co activator 1-alpha (PGC1α); (<b>c</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 1 (APPL1); (<b>d</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 2 (APPL2); (<b>e</b>) Adiponectin Receptor 1 (AdipoR1).</p>
Full article ">Figure 5 Cont.
<p>The abundance of mRNA expressed for markers involved in adiponectin signalling and oxidative capacity in human primary <span class="html-italic">rectus abdominus</span>-derived myotubes obtained from individuals that are obese treated for 24 h with O-1918 (25–200 nM). mRNA expression was normalised to housekeeping gene Cyclophilin and grouped data is reported as mean (arbitrary units) ± SEM. (<b>a</b>) Nuclear Factor of Activated T-Cells calcineurin dependent 1 (NFATc1); (<b>b</b>) Peroxisome proliferator-activated receptor gamma co activator 1-alpha (PGC1α); (<b>c</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 1 (APPL1); (<b>d</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 2 (APPL2); (<b>e</b>) Adiponectin Receptor 1 (AdipoR1).</p>
Full article ">Figure 6
<p>The abundance of mRNA expressed for markers involved in adiponectin signalling and oxidative capacity in human primary <span class="html-italic">rectus abdominus</span>-derived myotubes obtained from individuals that are obese and have type two diabetes mellitus treated for 24 h with O-1918 (25–200 nM). mRNA expression was normalised to housekeeping gene Cyclophilin and grouped data is reported as mean (arbitrary units) ± SEM. (<b>a</b>) Nuclear Factor of Activated T-Cells calcineurin dependent 1 (NFATc1); (<b>b</b>) Peroxisome proliferator-activated receptor gamma co activator 1-alpha (PGC1α); (<b>c</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 1 (APPL1); (<b>d</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 2 (APPL2); (<b>e</b>) Adiponectin Receptor 1 (AdipoR1).</p>
Full article ">Figure 6 Cont.
<p>The abundance of mRNA expressed for markers involved in adiponectin signalling and oxidative capacity in human primary <span class="html-italic">rectus abdominus</span>-derived myotubes obtained from individuals that are obese and have type two diabetes mellitus treated for 24 h with O-1918 (25–200 nM). mRNA expression was normalised to housekeeping gene Cyclophilin and grouped data is reported as mean (arbitrary units) ± SEM. (<b>a</b>) Nuclear Factor of Activated T-Cells calcineurin dependent 1 (NFATc1); (<b>b</b>) Peroxisome proliferator-activated receptor gamma co activator 1-alpha (PGC1α); (<b>c</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 1 (APPL1); (<b>d</b>) Adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 2 (APPL2); (<b>e</b>) Adiponectin Receptor 1 (AdipoR1).</p>
Full article ">
16 pages, 2400 KiB  
Article
P38 Regulates Kainic Acid-Induced Seizure and Neuronal Firing via Kv4.2 Phosphorylation
by Jia-hua Hu, Cole Malloy and Dax A. Hoffman
Int. J. Mol. Sci. 2020, 21(16), 5921; https://doi.org/10.3390/ijms21165921 - 18 Aug 2020
Cited by 8 | Viewed by 3582
Abstract
The subthreshold, transient A-type K+ current is a vital regulator of the excitability of neurons throughout the brain. In mammalian hippocampal pyramidal neurons, this current is carried primarily by ion channels comprising Kv4.2 α-subunits. These channels occupy the somatodendritic domains of these [...] Read more.
The subthreshold, transient A-type K+ current is a vital regulator of the excitability of neurons throughout the brain. In mammalian hippocampal pyramidal neurons, this current is carried primarily by ion channels comprising Kv4.2 α-subunits. These channels occupy the somatodendritic domains of these principle excitatory neurons and thus regulate membrane voltage relevant to the input–output efficacy of these cells. Owing to their robust control of membrane excitability and ubiquitous expression in the hippocampus, their dysfunction can alter network stability in a manner that manifests in recurrent seizures. Indeed, growing evidence implicates these channels in intractable epilepsies of the temporal lobe, which underscores the importance of determining the molecular mechanisms underlying their regulation and contribution to pathologies. Here, we describe the role of p38 kinase phosphorylation of a C-terminal motif in Kv4.2 in modulating hippocampal neuronal excitability and behavioral seizure strength. Using a combination of biochemical, single-cell electrophysiology, and in vivo seizure techniques, we show that kainic acid-induced seizure induces p38-mediated phosphorylation of Thr607 in Kv4.2 in a time-dependent manner. The pharmacological and genetic disruption of this process reduces neuronal excitability and dampens seizure intensity, illuminating a cellular cascade that may be targeted for therapeutic intervention to mitigate seizure intensity and progression. Full article
(This article belongs to the Special Issue P38 Signaling Pathway)
Show Figures

Figure 1

Figure 1
<p>p38 mitogen-activated protein kinase (MAPK) contributed to kainic acid-induced seizure in WT mice but not Kv4.2TA mice. (<b>A</b>) Time course of mean behavioral seizure score following kainic acid injection. The mean behavioral seizure score was significantly reduced in Kv4.2TA mice compared to WT mice. Furthermore, p38 inhibitor SB 203580 significantly reduced behavioral seizure score following kainic acid injection in WT mice but not in Kv4.2TA mice, <span class="html-italic">n</span> = 13–15 for each group, two-way ANOVA, * <span class="html-italic">p</span> &lt; 0.05. (<b>B</b>) Total behavioral seizure score for each group, <span class="html-italic">n</span> = 13–15 for each group, <span class="html-italic">t</span>-test, * <span class="html-italic">p</span> &lt; 0.05. (<b>C</b>) Latency to stage 3 seizure for each group. <span class="html-italic">n</span> = 13–15 for each group, <span class="html-italic">t</span>-test, ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 2
<p>Seizure induced by kainic acid triggers Kv4.2 T607 phosphorylation in a time-dependent manner in mouse hippocampus. (<b>A</b>) Time course of Kv4.2 phosphorylation at Thr602 and Thr607 by kainic acid administration (25 mg/kg, i.p.) in mouse hippocampus. (<b>B</b>) Statistical analysis of kainic acid-induced phosphorylation of Kv4.2 at Thr607 in mouse hippocampus, <span class="html-italic">n</span> = 3–8 in each group, <span class="html-italic">t</span>-test, ** <span class="html-italic">p</span> &lt; 0.01. (<b>C</b>) Statistical analysis of kainic acid-induced phosphorylation of Kv4.2 at Thr602 in mouse hippocampus, <span class="html-italic">n</span> = 3–8 in each group, <span class="html-italic">t</span>-test, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 3
<p>p38 MAPK contributes to kainic acid-induced Kv4.2 phosphorylation at T607. (<b>A</b>) SB 203580, a potent p38 inhibitor (20 mg/kg, i.p., 15 min), blocked kainic acid-induced phosphorylation of Kv4.2 T607 in mouse hippocampus. (<b>B</b>) Statistical analysis of the effect of SB 203580 on kainic acid-induced phosphorylation of Kv4.2 at Thr607 in mouse hippocampus, <span class="html-italic">n</span> = 4–6 in each group, <span class="html-italic">t</span>-test, ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 4
<p>p38 MAPK colocalizes with Kv4.2. (<b>A</b>) HEK293T cells were transfected with GFP-Kv4.2 and Flag-p38. Cells were fixed and stained with GFP and Flag to show co-localization. Scale bar: 20 μm. (<b>B</b>) High magnification images and line scan analysis of colocalization. Scale bar: 5 μm. (<b>C</b>) Mouse brains were co-stained with Kv4.2 and pp38 antibody. Phosphorylated p38 is localized in the cell body and dendrites as well. Scale bar: 20 μm. (<b>D</b>) High magnification images showing Kv4.2 and pp38 colocalized in dendrites, as indicated with arrow heads. Scale bar: 5 μm.</p>
Full article ">Figure 5
<p>Kainic acid activates p38 MAPK in both WT and Kv4.2TA mice. (<b>A</b>) Immunostaining analysis showed p38 phosphorylation increased with kainic acid administration (25 mg/kg, i.p., 30 min) in mouse hippocampus, <span class="html-italic">n</span> = 26 cells in each group, <span class="html-italic">t</span>-test, *** <span class="html-italic">p</span> &lt; 0.001. (<b>B</b>) Western blot analysis showed p38 phosphorylation increased with kainic acid administration (25 mg/kg, i.p., 30 min) in hippocampus in both WT and Kv4.2TA mice, <span class="html-italic">n</span> = 4–6 cells in each group, <span class="html-italic">t</span>-test, *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 6
<p>p38 impacts hippocampal pyramidal neuron excitability through Kv4.2. (<b>A</b>) Current step of +300 pA induces repetitive firing in pyramidal neurons recorded from WT and Kv4.2TA mice with or without SB 203580 treatment. Scale 40 mV/250 ms. Square current inset 300 pA. (<b>B</b>) Sequential somatic current injections increasing in magnitude reveal p38 kinase inhibition reduces AP firing frequency in WT hippocampal neurons at +300 pA relative to vehicle (<span class="html-italic">n</span> = 15 in vehicle, <span class="html-italic">n</span> = 19 in treatment; two-way ANOVA, * <span class="html-italic">p</span> &lt; 0.05). Kv4.2TA neurons display reduced firing frequency at +300 pA relative to WT in vehicle, which is augmented in the presence of SB 203580 such that current magnitudes of +200 and +250 pA also exhibit significant differences (<span class="html-italic">n</span> = 18 in vehicle, <span class="html-italic">n</span> = 14 in SB 203580; two-way ANOVA, * <span class="html-italic">p</span> &lt; 0.05; *** <span class="html-italic">p</span> &lt; 0.001). (<b>C</b>) Inter-spike intervals measured between the first two spikes in a train evoked by 150 pA injection display no significant difference among groups. Kruskal–Wallis test, <span class="html-italic">p</span> &gt; 0.05. (<b>D</b>) Ramp current injections evoke repetitive firing in all pyramidal neurons recorded in each condition. Arrow indicates point at which action potential (AP) threshold, rheobase, and latency to fire were measured. Ramp current inset 400 pA/s. (<b>E</b>) Minimum current to elicit AP firing at threshold (rheobase) is not significantly different among the populations. One-way ANOVA, <span class="html-italic">p</span> &gt; 0.05. (<b>F</b>) Latency to fire in response to ramp injection is not significantly different among populations. Kruskal–Wallis test, <span class="html-italic">p</span> &gt; 0.05.</p>
Full article ">
27 pages, 10738 KiB  
Review
Ursolic Acid-Based Derivatives as Potential Anti-Cancer Agents: An Update
by Vuyolwethu Khwaza, Opeoluwa O. Oyedeji and Blessing A. Aderibigbe
Int. J. Mol. Sci. 2020, 21(16), 5920; https://doi.org/10.3390/ijms21165920 - 18 Aug 2020
Cited by 125 | Viewed by 8675
Abstract
Ursolic acid is a pharmacologically active pentacyclic triterpenoid derived from medicinal plants, fruit, and vegetables. The pharmacological activities of ursolic acid have been extensively studied over the past few years and various reports have revealed that ursolic acid has multiple biological activities, which [...] Read more.
Ursolic acid is a pharmacologically active pentacyclic triterpenoid derived from medicinal plants, fruit, and vegetables. The pharmacological activities of ursolic acid have been extensively studied over the past few years and various reports have revealed that ursolic acid has multiple biological activities, which include anti-inflammatory, antioxidant, anti-cancer, etc. In terms of cancer treatment, ursolic acid interacts with a number of molecular targets that play an essential role in many cell signaling pathways. It suppresses transformation, inhibits proliferation, and induces apoptosis of tumor cells. Although ursolic acid has many benefits, its therapeutic applications in clinical medicine are limited by its poor bioavailability and absorption. To overcome such disadvantages, researchers around the globe have designed and developed synthetic ursolic acid derivatives with enhanced therapeutic effects by structurally modifying the parent skeleton of ursolic acid. These structurally modified compounds display enhanced therapeutic effects when compared to ursolic acid. This present review summarizes various synthesized derivatives of ursolic acid with anti-cancer activity which were reported from 2015 to date. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Multiple molecular targets modulated by UA.</p>
Full article ">Figure 2
<p>Structure of UA indicating the major active sites.</p>
Full article ">Figure 3
<p>Fontana and Xu ‘s UA derivatives.</p>
Full article ">Figure 4
<p>Gu’s, S. Zhang’s, Jin’s and T. Zhang’s work on UA derivatives.</p>
Full article ">Scheme 1
<p>Reagents and conditions: (<b>a</b>) Ac<sub>2</sub>O, DMAP, THF, rt; (<b>b</b>) (COCI)<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>. Rt; (<b>c</b>) HOCH<sub>2</sub> COOH, TEA, rt; (<b>d</b>) N-methylpiperazine, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (<b>e</b>) Benzylpiperazine, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (<b>f</b>) 10% Pd/C, H<sub>2</sub> anhydrous ethanol, rt.</p>
Full article ">Scheme 2
<p>Reagents and conditions: (<b>a</b>) N-Boc-Diamine, EDCl, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (<b>b</b>) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt.</p>
Full article ">Scheme 3
<p>Synthetic route for compounds <b>10</b>–<b>13</b>. Reagents and conditions: (<b>a</b>) NH<sub>2</sub>NHCOOCH<sub>3</sub>, CH(OC<sub>2</sub>H<sub>5</sub>)<sub>3</sub>; Ethanol(EtOH), MeONa, reflux, 48 h; (<b>b</b>) Br(CH<sub>2</sub>)nBr; Potassium carbonate (K<sub>2</sub>CO<sub>3</sub>), KI; (<b>c</b>) K<sub>2</sub>CO<sub>3</sub>, KI; (CH<sub>3</sub>)<sub>2</sub>CO, reflux, 10 h.</p>
Full article ">Scheme 4
<p>Synthesis of compounds <b>33</b>–<b>35</b>. Reagents and conditions: (<b>a</b>) Jones reagent acetone, 0 °C, 5 h, 90%; (<b>b</b>) Aldehydes, 5% NaOH, absolute EtOH, r.t 2 h, 30–75%; (<b>c</b>) 37% HCl, absolute EtOH, reflux, 8 h, 34–65%.</p>
Full article ">Scheme 5
<p>Synthesis of compounds <b>36</b>–<b>38</b>. Reagents and conditions: (<b>a</b>) Jones reagent acetone, 0 °C, 5 h; (<b>b</b>) EtOH, substituted o-amino benzaldehyde, KOH, reflux under N<sub>2</sub> atmosphere for 24 h.</p>
Full article ">Scheme 6
<p>Reagents and conditions: (<b>a</b>) Selectfluor®, dioxane, nitromethane, 80 °C, 24 h; (<b>b</b>) Jones reagent, acetone, ice; (c) m-CPBA 77%, CHCl<sub>3</sub>, r.t., 120 h; (d) p-toluenesulfonic acid monohydrate, CH<sub>2</sub>Cl<sub>2</sub>, r.t., 24 h; (e) R<sub>2</sub>NH<sub>2</sub>, dry THF, Et<sub>3</sub>N, T3P (50 wt% in THF), ice.</p>
Full article ">Scheme 7
<p>Reagents and conditions: (<b>a</b>) CuBr<sub>2</sub>, EtOAc, MeOH, r.t., 3 h; (<b>b</b>) KSCN, DMSO, 90 °C, 24 h.</p>
Full article ">Scheme 8
<p>Synthesis of UA hybrid compounds.</p>
Full article ">
4 pages, 183 KiB  
Editorial
Basic and Translational Models of Cooperative Oncogenesis
by Helena E. Richardson, Julia B. Cordero and Daniela Grifoni
Int. J. Mol. Sci. 2020, 21(16), 5919; https://doi.org/10.3390/ijms21165919 - 18 Aug 2020
Cited by 5 | Viewed by 2704
(This article belongs to the Special Issue Basic and Translational Models of Cooperative Oncogenesis)
17 pages, 499 KiB  
Review
PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy
by Ana Bocanegra, Ester Blanco, Gonzalo Fernandez-Hinojal, Hugo Arasanz, Luisa Chocarro, Miren Zuazo, Pilar Morente, Ruth Vera, David Escors and Grazyna Kochan
Int. J. Mol. Sci. 2020, 21(16), 5918; https://doi.org/10.3390/ijms21165918 - 18 Aug 2020
Cited by 19 | Viewed by 6425
Abstract
The use of monoclonal antibodies targeting PD-1/PD-L1 axis completely changed anticancer treatment strategies. However, despite the significant improvement in overall survival and progression-free survival of patients undergoing these immunotherapy treatments, the only clinically accepted biomarker with some prediction capabilities for the outcome of [...] Read more.
The use of monoclonal antibodies targeting PD-1/PD-L1 axis completely changed anticancer treatment strategies. However, despite the significant improvement in overall survival and progression-free survival of patients undergoing these immunotherapy treatments, the only clinically accepted biomarker with some prediction capabilities for the outcome of the treatment is PD-L1 expression in tumor biopsies. Nevertheless, even when having PD-L1-positive tumors, numerous patients do not respond to these treatments. Considering the high cost of these therapies and the risk of immune-related adverse events during therapy, it is necessary to identify additional biomarkers that would facilitate stratifying patients in potential responders and non-responders before the start of immunotherapies. Here, we review the utility of PD-L1 expression not only in tumor cells but in immune system cells and their influence on the antitumor activity of immune cell subsets. Full article
(This article belongs to the Special Issue PD-L1, a Master Regulator of Immunity 2.0)
Show Figures

Figure 1

Figure 1
<p>While clinical responses of cancer patients undergoing PD-1/PD-L1 blockade therapies may be explained by the suppression of the canonical PD-L1/PD-1 signaling axis, the fact that some patients with negative tumor PD-L1 expression still achieve objective responses highlights the contribution of PD-L1<sup>+</sup> systemic immunity—particularly the myeloid compartment—to this kind of treatment. sPD-L1, soluble PD-L1; MDSC, myeloid derived suppressor cells; CTC, circulating tumor cell; DC, dendritic cell; APC, antigen presenting cell.</p>
Full article ">
13 pages, 2754 KiB  
Article
Evaluation of the Individual and Combined Toxicity of Fumonisin Mycotoxins in Human Gastric Epithelial Cells
by Song Yu, Bingxuan Jia, Na Liu, Dianzhen Yu and Aibo Wu
Int. J. Mol. Sci. 2020, 21(16), 5917; https://doi.org/10.3390/ijms21165917 - 18 Aug 2020
Cited by 33 | Viewed by 3926
Abstract
Fumonisin contaminates food and feed extensively throughout the world, causing chronic and acute toxicity in human and animals. Currently, studies on the toxicology of fumonisins mainly focus on fumonisin B1 (FB1). Considering that FB1, fumonisin B2 (FB2) and fumonisin B3 (FB3) could coexist [...] Read more.
Fumonisin contaminates food and feed extensively throughout the world, causing chronic and acute toxicity in human and animals. Currently, studies on the toxicology of fumonisins mainly focus on fumonisin B1 (FB1). Considering that FB1, fumonisin B2 (FB2) and fumonisin B3 (FB3) could coexist in food and feed, a study regarding a single toxin, FB1, may not completely reflect the toxicity of fumonisin. The gastrointestinal tract is usually exposed to these dietary toxins. In our study, the human gastric epithelial cell line (GES-1) was used as in vitro model to evaluate the toxicity of fumonisin. Firstly, we found that they could cause a decrease in cell viability, and increase in membrane leakage, cell death and the induction of expression of markers for endoplasmic reticulum (ER) stress. Their toxicity potency rank is FB1 > FB2 >> FB3. The results also showed that the synergistic effect appeared in the combinations of FB1 + FB2 and FB1 + FB3. Nevertheless, the combinations of FB2 + FB3 and FB1 + FB2 + FB3 showed a synergistic effect at low concentration and an antagonistic effect at high concentration. We also found that myriocin (ISP-1) could alleviate the cytotoxicity induced by fumonisin in GES-1 cells. Finally, this study may help to determine or optimize the legal limits and risk assessment method of mycotoxins in food and feed and provide a potential method to block the fumonisin toxicity. Full article
Show Figures

Figure 1

Figure 1
<p>The chemical structure of major fumonisin B: (<b>A</b>) fumonisin B1; (<b>B</b>) fumonisin B2; and (<b>C</b>) fumonisin B3.</p>
Full article ">Figure 2
<p>The cytotoxicity of fumonisins B (FBs) on the human gastric epithelial cell line (GES-1) was shown to decrease the cell viability rate and increase the LDH leakage rate. (<b>A</b>) Cell viability was assessed by the cell count kit-8 cell proliferation assay. (<b>B</b>) Cell membrane integrity was determined by detecting the LDH leakage from the cell media using a cytotoxicity LDH detection kit. These data represented the mean ± SEM of the three individual experiments (** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, analysis of variance (ANOVA) test).</p>
Full article ">Figure 3
<p>FB1-induced cell death in GES-1 cells. (<b>A</b>) Dead cells were marked with Annexin V-FITC/PI dye. The GES-1 cell death rate was analyzed by flow cytometry. (<b>B</b>) These data represented the mean ± SEM of the three individual experiments (* <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, analysis of variance (ANOVA) test).</p>
Full article ">Figure 4
<p>FBs induced ER stress in the GES-1 cells. The levels of ER stress markers were determined by immunoblotting (<b>A</b>) and real-time PCR (<b>B</b>) after treatment with 20 μM FBs for 48 h. The data represented the mean ± SEM of the three individual experiments (* <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, analysis of variance (ANOVA) test).</p>
Full article ">Figure 5
<p>Interactive effects of FB1, FB2 and FB3 on the GES-1 cell viability. (<b>A</b>–<b>D</b>) GES-1 cells were treated with fumonisin alone or their mixtures for 48 h. The data represented the mean ± SEM of the three individual experiments (** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, analysis of variance (ANOVA) test).</p>
Full article ">Figure 6
<p>Myriocin (ISP-1) alleviated FB-induced GES-1 cytotoxicity. (<b>A</b>) Effect of ISP-1 on FB1-induced cytotoxicity. (<b>B</b>) Effect of ISP-1 on FB2-induced cytotoxicity. (<b>C</b>) Effect of ISP-1 on FB3 induced cytotoxicity. The data represented the mean ± SEM of the three individual experiments (** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, analysis of variance (ANOVA) test).</p>
Full article ">
19 pages, 12775 KiB  
Article
Toll-Like Receptor 5 of Golden Pompano Trachinotus ovatus (Linnaeus 1758): Characterization, Promoter Activity and Functional Analysis
by Ke-Cheng Zhu, Meng Wu, Dian-Chang Zhang, Hua-Yang Guo, Nan Zhang, Liang Guo, Bao-Suo Liu and Shi-Gui Jiang
Int. J. Mol. Sci. 2020, 21(16), 5916; https://doi.org/10.3390/ijms21165916 - 18 Aug 2020
Cited by 27 | Viewed by 3251
Abstract
Toll-like receptors (TLRs), as important pattern recognition receptors, represent a significant component of fish immune systems and play an important role in resisting the invasion of pathogenic microorganisms. The TLR5 subfamily contains two types of TLR5, the membrane form of TLR5 (TLR5M) and [...] Read more.
Toll-like receptors (TLRs), as important pattern recognition receptors, represent a significant component of fish immune systems and play an important role in resisting the invasion of pathogenic microorganisms. The TLR5 subfamily contains two types of TLR5, the membrane form of TLR5 (TLR5M) and the soluble form of TLR5 (TLR5S), whose detailed functions have not been completely elucidated. In the present study, we first identified two genes, TLR5M (ToTLR5M) and TLR5S (ToTLR5S), from golden pompano (Trachinotus ovatus). The full-length ToTLR5M and ToTLR5S cDNA are 3644 bp and 2329 bp, respectively, comprising an open reading frame (ORF) of 2673 bp, encoding 890 amino acids, and an ORF of 1935 bp, encoding 644 amino acids. Both the ToTLR5s possess representative TLR domains; however, only ToTLR5M has transmembrane and intracellular TIR domains. Moreover, the transcription of two ToTLR5s was significantly upregulated after stimulation by polyinosinic:polycytidylic acid (poly (I:C)), lipopolysaccharide (LPS), and flagellin in both immune-related tissues (liver, intestine, blood, kidney, and skin) and nonimmune-related tissue (muscle). Furthermore, the results of bioinformatic and promoter analysis show that the transcription factors GATA-1 (GATA Binding Protein 1), C/EBPalpha (CCAAT Enhancer Binding Protein Alpha), and ICSBP (Interferon (IFN) consensus sequence binding protein) may play a positive role in moderating the expression of two ToTLR5s. Overexpression of ToTLR5M and ToTLR5S notably increases NF-κB (nuclear factor kappa-B) activity. Additionally, the binding assay revealed that two rToTLR5s can bind specifically to bacteria and pathogen-associated molecular patterns (PAMPs) containing Vibrio harveyi, Vibrio anguillarum, Vibrio vulnificus, Escherichia coli, Photobacterium damselae, Staphylococcus aureus, Aeromonas hydrophila, LPS, poly(I:C), flagellin, and peptidoglycan (PGN). In conclusion, the present study may help to elucidate the function of ToTLR5M/S and clarify their possible roles in the fish immune response to bacterial infection. Full article
(This article belongs to the Section Molecular Biology)
Show Figures

Figure 1

Figure 1
<p>The full-length cDNA and deduced amino acid sequences of ToTLR5M (<b>A</b>) and ToTLR5S (<b>B</b>). The leucine-rich repeat (LRR) and LRR-NT domains are highlighted in light gray and by dotted lines, respectively. The LRR-CT domains are underlined in ToTLR5S (<b>B</b>). The transmembrane region is indicated by box and the Toll/IL-1 receptor (TIR) domain is marked with gray; termination codon is indicated with “*”.</p>
Full article ">Figure 2
<p>The domain features of the membrane form of TLR5 (TLR5M) and the soluble form of TLR5 (TLR5S) among vertebrates. (<b>A</b>) Multiple alignment of TLR5 deduced amino acid sequences. LRR represents leucine-rich repeats, red represents low-complexity region, LRR-CT represents LRR C-terminal region, blue represents transmembrane region, TIR represents Toll/interleukin-I receptor domain. (<b>B</b>) The amino acid sequence alignment of TLR5 TIR domains in various species. The GenBank accession numbers are shown in <a href="#app1-ijms-21-05916" class="html-app">Table S1</a>.</p>
Full article ">Figure 3
<p>The tissue expression of the <span class="html-italic">ToTLR5M</span> and <span class="html-italic">ToTLR5S</span> genes. The tissues included kidney, liver, stomach, spleen, intestine, brain, skin, gill, muscle, and blood. Elongation factor 1 alpha (<span class="html-italic">EF-1α</span>) acted as an internal reference to calibrate the cDNA templates. Mean ± standard error (SE) (<span class="html-italic">n</span> = 3) of each mRNA quantity was shown for each tissue examined. Different uppercase or lowercase letters indicate significant differences (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 4
<p><span class="html-italic">ToTLR5M</span> expressions in different tissues (liver, kidney, intestine, skin, muscle, and blood) after phosphate-buffered saline (PBS), flagellin, poly(I:C), and LPS challenge. <span class="html-italic">EF-1</span><span class="html-italic">α</span> acted as an internal control to calibrate the cDNA templates. All data are expressed as mean ± SE. Different letters show significant differences (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 5
<p><span class="html-italic">ToTLR5S</span> expressions in different tissues (liver, kidney, intestine, skin, muscle, and blood) after PBS, flagellin, poly(I:C), and LPS challenge. <span class="html-italic">EF-1</span><span class="html-italic">α</span> acted as an internal control to calibrate the cDNA templates. All data are expressed as mean ± SE. Different letters show significant differences (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 6
<p>Promoter activity analysis of <span class="html-italic">ToTLR5M</span> (<b>A</b>) and <span class="html-italic">ToTLR5S</span> (<b>B</b>). (<b>A</b>) Seven recombinant plasmids, denoted as ProT5M-1 (−1827 to +565), ProT5M-2 (−1566 to +565), ProT5M-3 (−1131 to +565), ProT5M-4 (−813 to +565), ProT5M-5 (−501 to +565), ProT5M-6 (−309 to +565), and ProT5M-7 (−120 to +565) were constructed and transfected into <span class="html-italic">Trachinotus ovatus</span> snout tissue (GPS) cells. (<b>B</b>) Seven recombinant plasmids, denoted ProT5S-1 (−1733 to +519), ProT5S-2 (−1358 to +519), ProT5S-3 (−1111 to +519), ProT5S-4 (−802 to +519), ProT5S-5 (−490 to +519), ProT5S-6 (−298 to +519), and ProT5S-7 (−154 to +519) were constructed and transfected into GPS cells. Different color boxes indicate binding sites located in different truncation regions. All data are expressed as mean ± SE in the picture (<span class="html-italic">n</span> = 5). * indicates significant differences (<span class="html-italic">p</span> &lt; 0.05). ** indicates extremely significant differences (<span class="html-italic">p</span> &lt; 0.01).</p>
Full article ">Figure 7
<p>Overexpression of two <span class="html-italic">ToTLR5</span> genes altered the expression levels of NF-κB. The cells were transfected with an empty vector or <span class="html-italic">ToTLR5s</span>-pcDNA3.1. Each of them was co-transfected with an NF-κB reporter plasmid. All data are expressed as mean ± SE. Different letters show significant differences (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 8
<p>SDS-PAGE (<b>A</b>) and Western blot (<b>B</b>) analysis of two purified recombinant ToTLR5s. (<b>A</b>) Lane M: standard protein marker; lane A1: purified recombinant ToTLR5M; lane A2: purified recombinant ToTLR5S. (<b>B</b>) Lane M: standard protein marker; lane B1: rToTLR5M; lane B2: rToTLR5S.</p>
Full article ">Figure 9
<p>ELISA analysis of the interaction between rToTLR5M (<b>A</b>,<b>C</b>) and rToTLR5S (<b>B</b>,<b>D</b>) to pathogen-associated molecular patterns (PAMPs) (<b>A</b>,<b>B</b>) and bacteria (<b>C</b>,<b>D</b>), respectively. The microtiter plates were coated with PAMPs and bacteria, and then incubated with different concentrations of recombinant protein. The interaction between protein and PAMPs/bacteria were detected by composite anti-His polyclonal antiserum at 450 nm. Results were representative of an average of three experiments.</p>
Full article ">
19 pages, 3232 KiB  
Article
Biochemical Characterization and Crystal Structure of a Novel NAD+-Dependent Isocitrate Dehydrogenase from Phaeodactylum tricornutum
by Shi-Ping Huang, Lu-Chun Zhou, Bin Wen, Peng Wang and Guo-Ping Zhu
Int. J. Mol. Sci. 2020, 21(16), 5915; https://doi.org/10.3390/ijms21165915 - 18 Aug 2020
Cited by 5 | Viewed by 3382
Abstract
The marine diatom Phaeodactylum tricornutum originated from a series of secondary symbiotic events and has been used as a model organism for studying diatom biology. A novel type II homodimeric isocitrate dehydrogenase from P. tricornutum (PtIDH1) was expressed, purified, and identified in detail [...] Read more.
The marine diatom Phaeodactylum tricornutum originated from a series of secondary symbiotic events and has been used as a model organism for studying diatom biology. A novel type II homodimeric isocitrate dehydrogenase from P. tricornutum (PtIDH1) was expressed, purified, and identified in detail through enzymatic characterization. Kinetic analysis showed that PtIDH1 is NAD+-dependent and has no detectable activity with NADP+. The catalytic efficiency of PtIDH1 for NAD+ is 0.16 μM−1·s−1 and 0.09 μM−1·s−1 in the presence of Mn2+ and Mg2+, respectively. Unlike other bacterial homodimeric NAD-IDHs, PtIDH1 activity was allosterically regulated by the isocitrate. Furthermore, the dimeric structure of PtIDH1 was determined at 2.8 Å resolution, and each subunit was resolved into four domains, similar to the eukaryotic homodimeric NADP-IDH in the type II subfamily. Interestingly, a unique and novel C-terminal EF-hand domain was first defined in PtIDH1. Deletion of this domain disrupted the intact dimeric structure and activity. Mutation of the four Ca2+-binding sites in the EF-hand significantly reduced the calcium tolerance of PtIDH1. Thus, we suggest that the EF-hand domain could be involved in the dimerization and Ca2+-coordination of PtIDH1. The current report, on the first structure of type II eukaryotic NAD-IDH, provides new information for further investigation of the evolution of the IDH family. Full article
(This article belongs to the Section Biochemistry)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Phylogenetic analysis of IDHs from different species. The analysis involved 45 IDH sequences and a neighbor-joining tree with 1000 bootstraps and was created by MEGA 7.0. The UniProt entry numbers are noted in parentheses. PtIDH1 is marked by a purple star.</p>
Full article ">Figure 2
<p>Structure-based amino acid sequence alignment of PtIDH1 with other IDHs. (<b>A</b>) Comparison of the N-terminal amino acid sequences of PtIDH1 with other IDHs. The putative mitochondrial targeting peptide sequences are underlined in black, and the possible cleavage sites are indicated by dots. (<b>B</b>) The substrate and metal ion binding conserved amino acid residues of the IDH family are indicated by triangles. (<b>C</b>) The putative conserved residues implicated in PtIDH1 coenzyme binding are compared with other homomeric NAD(P)-IDHs. The residues that directly or indirectly interact with the 2′-phosphate of NADP<sup>+</sup> are indicated by stars. (<b>D</b>) Comparison of the C-terminal amino acid sequence of PtIDH1 with other IDHs. The putative EF-hand domain sequence is underlined in black. The Ca<sup>2+</sup>-binding sites are indicated by red clubs. The secondary structures of human cytosolic NADP-IDH (PDB entry: 1T0L) was placed above the alignment.</p>
Full article ">Figure 3
<p>Overexpression, purification, and oligomeric state determination of PtIDH1. (<b>A</b>) Gel filtration chromatography elution profile of PtIDH1 from the Superdex 200 (10/300) column. The lower right insert panel shows the protein purity detection by 12% SDS-PAGE. (<b>B</b>) Elution profile of dimeric PtIDH1 (Peak 2 from A). All the flow rates of gel filtration chromatography were 0.5 mL·min<sup>−1</sup>.</p>
Full article ">Figure 4
<p>Hill plots of PtIDH1 activity. The <span class="html-italic">n</span><sub>H</sub> values of PtIDH1 for isocitrate were 1.43 ± 0.14 and 1.36 ± 0.03 in the presence of Mn<sup>2+</sup> and Mg<sup>2+</sup>, respectively. The mean ± SD values were obtained from three independent replicates.</p>
Full article ">Figure 5
<p>Effect of pH, temperature, and NADH on the NAD<sup>+</sup>-linked activity of PtIDH1. (<b>A</b>) Effect of pH on the activity of PtIDH1 in the presence of Mn<sup>2+</sup> and Mg<sup>2+</sup>, respectively. (<b>B</b>) Effect of temperature on the activity of PtIDH1 in the presence of Mn<sup>2+</sup> and Mg<sup>2+</sup>. (<b>C</b>) Heat-inactivation profiles of PtIDH1 in the presence of Mn<sup>2+</sup> and Mg<sup>2+</sup>. (<b>D</b>) Effect of NADH on the activity of PtIDH1 with Mn<sup>2+</sup>. All values are displayed as the means of at least three independent measurements.</p>
Full article ">Figure 5 Cont.
<p>Effect of pH, temperature, and NADH on the NAD<sup>+</sup>-linked activity of PtIDH1. (<b>A</b>) Effect of pH on the activity of PtIDH1 in the presence of Mn<sup>2+</sup> and Mg<sup>2+</sup>, respectively. (<b>B</b>) Effect of temperature on the activity of PtIDH1 in the presence of Mn<sup>2+</sup> and Mg<sup>2+</sup>. (<b>C</b>) Heat-inactivation profiles of PtIDH1 in the presence of Mn<sup>2+</sup> and Mg<sup>2+</sup>. (<b>D</b>) Effect of NADH on the activity of PtIDH1 with Mn<sup>2+</sup>. All values are displayed as the means of at least three independent measurements.</p>
Full article ">Figure 6
<p>The structural characterizations of PtIDH1. (<b>A</b>) Overall structure of PtIDH1-Apo. PtIDH1 shows a dimeric structure and contains two subunits, which are colored light orange (subunit A) or spring-green (subunit B). (<b>B</b>) View of the monomer of the PtIDH1. Each subunit contains four domains: a large domain, a small domain, a clasp domain, and an EF-hand domain, which are colored green, cyan, yellow, and orange, respectively. (<b>C</b>) Monomer comparison of PtIDH1 (green) and HcIDH (light blue) shows the difference in the C-terminus (in red). (<b>D</b>) Overlay of the monomer of PtIDH (green) and AtIDH (yellow). The arrows, pointing towards the red ribbon of PtIDH1, represent the structural differences between PtIDH1 and AtIDH.</p>
Full article ">Figure 7
<p>Characterization of the mutants. (<b>A</b>) Overexpression and purification of PtIDH1-EF. Gel filtration chromatography elution profile of PtIDH1-EF from the Superdex 200 (10/300) column with a flow rate of 0.5 mL·min<sup>−1</sup>. The inset panel shows the protein purity detection by 12% SDS-PAGE. (<b>B</b>) Modeling studies of Ca<sup>2+</sup> co-ordination by the EF-hand motif of PtIDH1. Ca<sup>2+</sup> coordinating residues (X, Y, Z, -Y, -Z, and -X) are indicated as sticks and are labeled. The Ca<sup>2+</sup> ion and the water molecule are indicated in yellow and red, respectively. Side chain, sc; backbone, bb; water molecule, w. (<b>C</b>) Circular dichroism (CD) spectra of the wild-type PtIDH1 and its mutant (M4A). (<b>D</b>) Effect of Ca<sup>2+</sup> on the activity of wild-type PtIDH1 and its mutant (M4A). The assay mixtures were prepared as described for a standard reaction in the presence of 2 mM Mn<sup>2+</sup>, and the Ca<sup>2+</sup> concentration was changed by extra addition. A reaction mixture without added Ca<sup>2+</sup> was used as a control. *** <span class="html-italic">p</span> &lt; 0.001 vs. control.</p>
Full article ">
23 pages, 4350 KiB  
Article
Comparative Transcriptomic Analysis of the Development of Sepal Morphology in Tomato (Solanum Lycopersicum L.)
by Jingyi Liu, Meijing Shi, Jing Wang, Bo Zhang, Yushun Li, Jin Wang, Ahmed. H. El-Sappah and Yan Liang
Int. J. Mol. Sci. 2020, 21(16), 5914; https://doi.org/10.3390/ijms21165914 - 18 Aug 2020
Cited by 20 | Viewed by 4490
Abstract
Sepal is an important component of the tomato flower and fruit that typically protects the flower in bud and functions as a support for petals and fruits. Moreover, sepal appearance influences the commercial property of tomato nowadays. However, the phenotype information and development [...] Read more.
Sepal is an important component of the tomato flower and fruit that typically protects the flower in bud and functions as a support for petals and fruits. Moreover, sepal appearance influences the commercial property of tomato nowadays. However, the phenotype information and development mechanism of the natural variation of sepal morphology in the tomato is still largely unexplored. To study the developmental mechanism and to determine key genes related to downward sepal in the tomato, we compared the transcriptomes of sepals between downward sepal (dsp) mutation and the wild-type by RNA sequencing and found that the differentially expressed genes were dominantly related to cell expansion, auxin, gibberellins and cytokinin. dsp mutation affected cell size and auxin, and gibberellins and cytokinin contents in sepals. The results showed that cell enlargement or abnormal cell expansion in the adaxial part of sepals in dsp. As reported, auxin, gibberellins and cytokinin were important factors for cell expansion. Hence, dsp mutation regulated cell expansion to control sepal morphology, and auxin, gibberellins and cytokinin may mediate this process. One ARF gene and nine SAUR genes were dramatically upregulated in the sepal of the dsp mutant, whereas seven AUX/IAA genes were significantly downregulated in the sepal of dsp mutant. Further bioinformatic analyses implied that seven AUX/IAA genes might function as negative regulators, while one ARF gene and nine SAUR genes might serve as positive regulators of auxin signal transduction, thereby contributing to cell expansion in dsp sepal. Thus, our data suggest that 17 auxin-responsive genes are involved in downward sepal formation in the tomato. This study provides valuable information for dissecting the molecular mechanism of sepal morphology control in the tomato. Full article
(This article belongs to the Collection Genetics and Molecular Breeding in Plants)
Show Figures

Figure 1

Figure 1
<p>Phenotypes of WT and <span class="html-italic">dsp (downward sepal)</span> sepal at different developmental stages. (<b>a</b>) Sepal of the wild type and the <span class="html-italic">dsp</span> at different stages. (<b>b</b>) Sepal upturned degree and sepal rolling index at different stages. <span class="html-italic">p</span>-values were determined by <span class="html-italic">t</span>-test. * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01 (<span class="html-italic">t</span>-test).</p>
Full article ">Figure 2
<p>Analysis of transcriptomes from sepals of wild-type and <span class="html-italic">dsp</span> plants. (<b>a</b>) The number of clean reads obtained from the WT and <span class="html-italic">dsp</span> in stage 3 and stage 4, and the percentage of clean reads mapped to the genome. (<b>b</b>) The number of up- or down-regulated DEGs for WT vs. <span class="html-italic">dsp</span> at stage 3 and stage 4. (<b>c</b>) Venn diagram analysis of both upregulated genes of stage 3 and stage 4 groups. (<b>d</b>) Venn diagram analysis of both downregulated genes of stage 3 and stage 4 groups. (<b>e</b>) Venn diagram analysis of genes with both DEGs of stage 3 and stage 4 groups. (<b>f</b>,<b>g</b>) The volcano map of differentially expressed genes (DEGs) in stage 3 and stage 4 groups. Red dots indicate upregulated genes; blue dots indicate downregulated genes; grey dots represent no significant difference.</p>
Full article ">Figure 3
<p>The Gene Ontology (GO) and (Kyoto Encyclopedia of Genes and Genomes) KEGG enrichment analysis of DEGs. (<b>a</b>) The GO enrichment analysis. The top ten enriched biological processes, molecular function and cellular component GO terms for DEGs. The x-axis represents GO term. The y-axis represents the significance level of enrichment (−log<sub>10</sub> FDR—false discovery rate). (<b>b</b>) The KEGG enrichment scatter plot of DEGs. The y-axis represents the name of the pathway, and the x-axis represents the rich factor, the degree of KEGG pathway enrichment. Top 20 KEGG pathway enrichments with DEGs were showed. Dot size represents the number of genes and the color indicates the <span class="html-italic">p</span>-value.</p>
Full article ">Figure 4
<p>Cluster analysis of differentially expressed genes. (<b>a</b>) K-means clustering of DEGs in sepals at stage 3 and 4 of the WT and <span class="html-italic">dsp</span> plants. Red and blue in the heat maps represent up-regulated and down-regulated genes, respectively. (<b>b</b>) The trend chart of each subcluster. (<b>c</b>) The GO enrichment analysis of genes in each cluster.</p>
Full article ">Figure 5
<p>The paraffin cross-section of the sepal of WT and <span class="html-italic">dsp</span>. (<b>A</b>–<b>D</b> and <b>I</b>) Stage 3 to 7 of WT sepal. (<b>E</b>–<b>H</b> and <b>J</b>) Stage 3 to 7 of <span class="html-italic">dsp</span> sepal. (<b>K</b>) The average area of sepal cells in unit view. The area of unit view of A, B, E and F = 0.01mm<sup>2</sup>; C and G = 0.09 mm<sup>2</sup>; D, H–J = 0.25 mm<sup>2</sup>. The cells in &gt; 3 unit views were counted. * <span class="html-italic">p</span> &lt; 0.05 (<span class="html-italic">t</span>-test), ** <span class="html-italic">p</span> &lt; 0.01 (<span class="html-italic">t</span>-test).</p>
Full article ">Figure 6
<p>The result of clustering analysis for the differentially expressed genes (DEGs). (<b>a</b>) Auxin related genes. (<b>b</b>) Cytokinin related genes. (<b>c</b>) Gibberellin related genes. Blue and red colors indicate genes with higher expression and lower expression, respectively.</p>
Full article ">Figure 7
<p>Analysis of hormones in sepals. (<b>a</b>) IAA (indole-3-acetic acid) content of sepals in the wild type and <span class="html-italic">dsp</span> from stage 3 to stage 6. (<b>b</b>) Cytokinin content of sepals in the wild type and <span class="html-italic">dsp</span> from stage 3 to stage 6. (<b>c</b>) Gibberellin content of sepals in the wild type and <span class="html-italic">dsp</span> from stage 3 to stage 6. * <span class="html-italic">p</span> &lt;0.05, ** <span class="html-italic">p</span>&lt; 0.01 (<span class="html-italic">t</span>-test).</p>
Full article ">Figure 8
<p>KEGG graph of auxin signal transduction pathway. Up-regulated, down-regulated and unchanged genes are shown in red, green and black boxes, respectively. “ARF” in the red box indicates the one <span class="html-italic">ARF</span> gene (<span class="html-italic">Solyc04g081240.2</span>). “AUX/IAA” in the green box represents the seven <span class="html-italic">AUX/IAA</span> genes (<span class="html-italic">Solyc06g008590.2</span>, <span class="html-italic">Solyc08g021820.2</span>, <span class="html-italic">Solyc09g083290.2</span>, <span class="html-italic">Solyc09g090910.1</span>, <span class="html-italic">Solyc04g076850.2</span>, <span class="html-italic">Solyc06g053830.2</span>, <span class="html-italic">Solyc06g053840.2</span>). “SAUR“ in the red box indicates the nine <span class="html-italic">SAUR</span> genes (<span class="html-italic">Solyc05g025920.2</span>, <span class="html-italic">Solyc05g056440.1</span>, <span class="html-italic">Solyc01g110920.2</span>, <span class="html-italic">Solyc03g082530.1</span>, <span class="html-italic">Solyc06g053290.1</span>, <span class="html-italic">Solyc06g072650.1</span>, <span class="html-italic">Solyc09g009980.1</span>, <span class="html-italic">Solyc07g066560.1</span>, <span class="html-italic">Solyc02g084010.1</span>).</p>
Full article ">Figure 9
<p>Measurement of sepal traits. (<b>a</b>) Measurement of sepal length (SEL) and sepal width (SEW). (<b>b</b>) Measurement of Sepal Upturned Degree (SEUD) and Sepal Rolling Index (SERI). SEUD-Sepal Upturned Degree (α). α = arctan (H/L1) (°). H represents the vertical distance between the furthest point from sepal to stalk in the horizontal line and the base line; L1 is the longest distance from sepal to stalk. SERI-Sepal Rolling Index = (SEL − L2)/SEL. SEL, Sepal Length; L2 is the distance from the sepal apex to base point.</p>
Full article ">
Previous Issue
Back to TopTop